×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Nektar Therapeutics. (NKTR) NASDAQ

$1.32 (0.03) (-2.22%)

Market Cap: $247.88M

As of 04/18/24 04:00 PM EDT. Market closed.

(NKTR)

Nektar Therapeutics. (NKTR)
NASDAQ

$1.32
(0.03) (-2.22%)

Market Cap: $247.88M

As of 04/18/24 04:00 PM EDT. Market closed.

Add to Portfolio

nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include ... read more

nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Howard Robin
Full Time Employees
820
CEO Compensation (Base)
$968,921
CEO Compensation (Total)
$13.33M
URL
Address
455 Mission Bay Blvd S, California, San Francisco, 94158-2158.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Howard Robin
Full Time Employees
820
CEO Compensation (Base)
$968,921
CEO Compensation (Total)
$13.33M
Address
455 Mission Bay Blvd S, California, San Francisco, 94158-2158.
PRICE CHART FOR NEKTAR THERAPEUTICS
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.35
Previous Close
$1.35
Days Range
$1.27 - $1.36
52 week range
$0.41 - $1.75
Volume
3,575,770
Avg. Volume (30 days)
3,508,363
Market Cap
$247.88M
Dividend Yield
-
P/E
(0.90)
Shares Outstanding
183,617,817
Open
$1.35
Previous Close
$1.35
Days Range
$1.27 - $1.36
52 week range
$0.41 - $1.75
Volume
3,575,770
Avg. Volume (30 days)
3,508,363
Market Cap
$247.88M
Dividend Yield
-
P/E
(0.90)
Shares Outstanding
183,617,817
FINANCIAL STATEMENTS FOR NEKTAR THERAPEUTICS
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR NEKTAR THERAPEUTICS
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Zalevsky JonathanChief R&D OfficerFeb 20, 2024 Sale$0.689,0146,130265,025Feb 22, 2024, 08:19 PM
Wilson Mark AndrewChief Legal OfficerFeb 20, 2024 Sale$0.687,6065,172236,674Feb 22, 2024, 08:17 PM
ROBIN HOWARD WPresident & CEOFeb 20, 2024 Sale$0.6820,03313,622879,889Feb 22, 2024, 08:16 PM
Zalevsky JonathanChief R&D OfficerNov 17, 2023 Sale$0.499,6464,727274,039Nov 20, 2023, 09:02 PM
Wilson Mark AndrewChief Legal OfficerNov 17, 2023 Sale$0.497,1793,518243,780Nov 20, 2023, 09:00 PM
ROBIN HOWARD WPresident & CEONov 17, 2023 Sale$0.4919,8779,740899,922Nov 20, 2023, 08:58 PM
Curet MyriamDirectorSep 18, 2023 Sale$0.694,3593,00827,418Sep 20, 2023, 08:09 PM
CHESS ROBERTDirectorSep 22, 2022 Sale$0.6710,2006,834274,773Sep 20, 2023, 08:08 PM
Ajer Jeffrey RobertDirectorSep 18, 2023 Sale$0.694,3593,00834,153Sep 20, 2023, 08:06 PM
Zalevsky JonathanChief R&D OfficerAug 16, 2023 Sale$0.789,7037,568283,685Aug 17, 2023, 08:08 PM
Wilson Mark AndrewChief Legal OfficerAug 16, 2023 Sale$0.787,2215,632250,959Aug 17, 2023, 08:07 PM
ROBIN HOWARD WPresident & CEOAug 16, 2023 Sale$0.7819,99815,598919,799Aug 17, 2023, 08:06 PM
WHITFIELD ROY ADirectorJun 14, 2023 Sale$0.5730,00017,100216,250Jun 15, 2023, 06:26 PM
Zalevsky JonathanChief R&D OfficerMay 16, 2023 Sale$0.729,7917,050293,388May 17, 2023, 08:29 PM
Wilson Mark AndrewChief Legal OfficerMay 16, 2023 Sale$0.727,5435,431257,680May 17, 2023, 08:28 PM
ROBIN HOWARD WPresident & CEOMay 16, 2023 Sale$0.7220,36114,660939,797May 17, 2023, 08:27 PM
Zalevsky JonathanChief R&D OfficerFeb 16, 2023 Sale$3.0010,48431,452303,179Feb 17, 2023, 09:00 PM
Wilson Mark AndrewChief Legal OfficerFeb 16, 2023 Sale$3.008,27524,825265,223Feb 17, 2023, 08:59 PM
Thomsen Jillian B.Chief Financial OfficerFeb 16, 2023 Sale$3.0010,26730,801313,497Feb 17, 2023, 08:58 PM
ROBIN HOWARD WPresident & CEOFeb 16, 2023 Sale$3.0019,63558,905960,158Feb 17, 2023, 08:57 PM
Zalevsky JonathanChief R&D OfficerNov 16, 2022 Sale$3.5713,46048,052313,663Nov 18, 2022, 06:05 PM
Wilson Mark AndrewChief Legal OfficerNov 16, 2022 Sale$3.578,69031,023272,498Nov 18, 2022, 06:04 PM
Thomsen Jillian B.Chief Financial OfficerNov 16, 2022 Sale$3.5711,09539,609323,764Nov 18, 2022, 06:03 PM
ROBIN HOWARD WPresident & CEONov 16, 2022 Sale$3.5738,014135,710979,793Nov 18, 2022, 06:02 PM
Curet MyriamDirectorSep 23, 2022 Sale$3.164,19813,26631,777Sep 26, 2022, 07:32 PM
Ajer Jeffrey RobertDirectorSep 23, 2022 Sale$3.164,19813,26638,512Sep 26, 2022, 07:25 PM
CHESS ROBERTDirectorSep 22, 2022 Sale$3.195,10016,269228,179Sep 26, 2022, 07:23 PM
EASTHAM KARINDirectorSep 13, 2022 Sale$3.6121,26776,77413,033Sep 14, 2022, 06:01 PM
Zalevsky JonathanChief R&D OfficerAug 18, 2022 Sale$4.6573,716342,779327,123Aug 19, 2022, 06:27 PM
Zalevsky JonathanChief R&D OfficerAug 16, 2022 Sale$4.7610,56050,266400,839Aug 17, 2022, 07:41 PM
Wilson Mark AndrewSVP & General CounselAug 16, 2022 Sale$4.763,18915,180281,188Aug 17, 2022, 07:40 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerAug 16, 2022 Sale$4.762,0069,549334,859Aug 17, 2022, 07:40 PM
ROBIN HOWARD WPresident & CEOAug 16, 2022 Sale$4.7613,75965,4931,017,807Aug 17, 2022, 07:39 PM
Zalevsky JonathanChief R&D OfficerMay 16, 2022 Sale$3.9521,67385,608276,399May 17, 2022, 09:40 PM
Wilson Mark AndrewSVP & General CounselMay 16, 2022 Sale$3.953,13612,387117,939May 17, 2022, 09:38 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerMay 16, 2022 Sale$3.955,84123,072170,427May 17, 2022, 09:36 PM
ROBIN HOWARD WPresident & CEOMay 16, 2022 Sale$3.9536,529144,290620,941May 17, 2022, 09:35 PM
NORTHCOTT JOHNSVP & Chief Commercial OfficerMay 16, 2022 Sale$3.954,59218,138223,210May 17, 2022, 09:33 PM
Labrucherie Gil MSVP, COO & CFOMay 16, 2022 Sale$3.9517,44868,920312,905May 17, 2022, 09:32 PM
Zalevsky JonathanChief R&D OfficerFeb 16, 2022 Sale$10.9510,912119,486274,122Feb 18, 2022, 06:20 PM
Wilson Mark AndrewSVP & General CounselFeb 16, 2022 Sale$10.953,66140,088121,075Feb 18, 2022, 06:18 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 16, 2022 Sale$10.952,36325,875165,318Feb 18, 2022, 06:18 PM
ROBIN HOWARD WPresident & CEOFeb 16, 2022 Sale$10.9512,480136,656589,020Feb 18, 2022, 06:16 PM
NORTHCOTT JOHNSVP & Chief Commercial OfficerFeb 16, 2022 Sale$10.954,85253,129227,802Feb 18, 2022, 06:15 PM
Labrucherie Gil MSVP, COO & CFOFeb 16, 2022 Sale$10.957,57982,990301,603Feb 18, 2022, 06:14 PM
Labrucherie Gil MSVP, COO & CFONov 18, 2021 Sale$12.693,00038,070256,682Nov 18, 2021, 06:06 PM
Labrucherie Gil MSVP, COO & CFONov 16, 2021 Sale$13.1621,149278,321259,682Nov 18, 2021, 06:06 PM
Zalevsky JonathanChief R&D OfficerNov 16, 2021 Sale$13.1620,869274,636232,084Nov 17, 2021, 06:11 PM
Wilson Mark AndrewSVP & General CounselNov 16, 2021 Sale$13.166,56486,38286,436Nov 17, 2021, 06:09 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerNov 16, 2021 Sale$13.166,74188,712145,981Nov 17, 2021, 06:08 PM
ROBIN HOWARD WPresident & CEONov 16, 2021 Sale$13.1642,773562,893475,450Nov 17, 2021, 06:07 PM
NORTHCOTT JOHNSVP & Chief Commercial OfficerNov 16, 2021 Sale$13.166,06179,763194,854Nov 17, 2021, 06:06 PM
GREER R SCOTTDirectorNov 09, 2021 Option Exercise$12.8012,500160,000293,374Nov 09, 2021, 05:05 PM
Curet MyriamDirectorSep 22, 2021 Sale$17.783,66565,16425,775Sep 24, 2021, 06:14 PM
CHESS ROBERTDirectorSep 22, 2021 Sale$17.944,60082,524279,873Sep 24, 2021, 06:13 PM
Ajer Jeffrey RobertDirectorSep 22, 2021 Sale$17.783,66565,16432,510Sep 24, 2021, 06:12 PM
WHITFIELD ROY ADirectorSep 16, 2021 Option Exercise$13.8040,000552,000225,850Sep 17, 2021, 06:44 PM
CHESS ROBERTDirectorSep 09, 2021 Option Exercise$13.8010,279141,850284,552Sep 10, 2021, 06:03 PM
CHESS ROBERTDirectorSep 08, 2021 Option Exercise$13.808,000110,400282,273Sep 10, 2021, 06:03 PM
CHESS ROBERTDirectorSep 09, 2021 Sale$16.0210,279164,670274,273Sep 10, 2021, 06:03 PM
CHESS ROBERTDirectorSep 08, 2021 Sale$16.008,000128,000274,273Sep 10, 2021, 06:03 PM
GREER R SCOTTDirectorAug 31, 2021 Option Exercise$12.7045,000571,500270,674Aug 31, 2021, 06:26 PM
Zalevsky JonathanChief R&D OfficerAug 16, 2021 Sale$13.837,662105,965212,803Aug 18, 2021, 07:04 PM
Wilson Mark AndrewSVP & General CounselAug 16, 2021 Sale$13.831,91026,41572,900Aug 18, 2021, 07:02 PM
ROBIN HOWARD WPresident & CEOAug 16, 2021 Sale$13.8311,515159,252424,123Aug 18, 2021, 07:01 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerAug 16, 2021 Sale$13.8313,339184,478137,822Aug 18, 2021, 07:00 PM
NORTHCOTT JOHNSVP & Chief Commercial OfficerAug 16, 2021 Sale$13.836,19285,635200,915Aug 18, 2021, 06:59 PM
Labrucherie Gil MSVP, COO & CFOAug 17, 2021 Sale$13.563,00040,680240,231Aug 18, 2021, 06:58 PM
Labrucherie Gil MSVP, COO & CFOAug 16, 2021 Sale$13.837,867108,801243,231Aug 18, 2021, 06:58 PM
CHESS ROBERTDirectorJul 22, 2021 Option Exercise$13.80911,256280,664Jul 22, 2021, 07:13 PM
CHESS ROBERTDirectorJul 21, 2021 Option Exercise$13.803,52448,631284,097Jul 22, 2021, 07:13 PM
CHESS ROBERTDirectorJul 20, 2021 Option Exercise$13.802,10629,063282,679Jul 22, 2021, 07:13 PM
CHESS ROBERTDirectorJul 22, 2021 Sale$16.80911,529280,573Jul 22, 2021, 07:13 PM
CHESS ROBERTDirectorJul 21, 2021 Sale$16.813,52459,238280,573Jul 22, 2021, 07:13 PM
CHESS ROBERTDirectorJul 20, 2021 Sale$16.802,10635,381280,573Jul 22, 2021, 07:13 PM
Labrucherie Gil MSVP, COO & CFOMay 17, 2021 Sale$18.307,898144,533251,098May 19, 2021, 07:04 PM
CHESS ROBERTDirectorMay 12, 2021 Option Exercise$13.808,000110,400288,573May 14, 2021, 06:05 PM
CHESS ROBERTDirectorMay 12, 2021 Sale$19.348,000154,720280,573May 14, 2021, 06:05 PM
CHESS ROBERTDirectorApr 14, 2021 Option Exercise$13.808,000110,400288,573Apr 16, 2021, 06:02 PM
CHESS ROBERTDirectorApr 14, 2021 Sale$18.988,000151,840280,573Apr 16, 2021, 06:02 PM
Zalevsky JonathanChief R&D OfficerFeb 16, 2021 Sale$22.3724,141540,034266,176Feb 18, 2021, 07:07 PM
Wilson Mark AndrewSVP & General CounselFeb 16, 2021 Sale$22.372,17348,61076,727Feb 18, 2021, 07:06 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 16, 2021 Sale$22.3711,705261,841164,552Feb 18, 2021, 07:05 PM
ROBIN HOWARD WPresident & CEOFeb 16, 2021 Sale$22.3711,495257,143447,198Feb 18, 2021, 07:04 PM
NORTHCOTT JOHNSVP & Chief Commercial OfficerFeb 16, 2021 Sale$22.3715,358343,558213,192Feb 18, 2021, 07:03 PM
Labrucherie Gil MSVP, COO & CFOFeb 16, 2021 Sale$22.377,977178,445258,996Feb 18, 2021, 07:03 PM
Wilson Mark AndrewSVP & General CounselFeb 03, 2021 Option Exercise$8.805,34447,02784,244Feb 04, 2021, 08:44 PM
Wilson Mark AndrewSVP & General CounselFeb 03, 2021 Sale$19.455,344103,94178,900Feb 04, 2021, 08:44 PM
ROBIN HOWARD WPresident & CEOFeb 04, 2021 Option Exercise$8.80150,0001,320,000608,693Feb 04, 2021, 08:43 PM
ROBIN HOWARD WPresident & CEOFeb 03, 2021 Option Exercise$8.80150,0001,320,000608,693Feb 04, 2021, 08:43 PM
ROBIN HOWARD WPresident & CEOFeb 02, 2021 Option Exercise$8.80150,0001,320,000608,693Feb 04, 2021, 08:43 PM
ROBIN HOWARD WPresident & CEOFeb 04, 2021 Sale$20.29150,0003,042,906516,830Feb 04, 2021, 08:43 PM
ROBIN HOWARD WPresident & CEOFeb 03, 2021 Sale$19.72150,0002,958,000458,693Feb 04, 2021, 08:43 PM
ROBIN HOWARD WPresident & CEOFeb 02, 2021 Sale$19.77150,0002,966,025469,193Feb 04, 2021, 08:43 PM
Labrucherie Gil MSVP, COO & CFOFeb 04, 2021 Option Exercise$8.8050,000440,000316,973Feb 04, 2021, 08:42 PM
Labrucherie Gil MSVP, COO & CFOFeb 03, 2021 Option Exercise$8.8050,000440,000316,973Feb 04, 2021, 08:42 PM
Labrucherie Gil MSVP, COO & CFOFeb 02, 2021 Option Exercise$8.8050,000440,000316,973Feb 04, 2021, 08:42 PM
Labrucherie Gil MSVP, COO & CFOFeb 04, 2021 Sale$19.8150,000990,500266,973Feb 04, 2021, 08:42 PM
Labrucherie Gil MSVP, COO & CFOFeb 03, 2021 Sale$19.6150,000980,500266,973Feb 04, 2021, 08:42 PM
Labrucherie Gil MSVP, COO & CFOFeb 02, 2021 Sale$20.1750,0001,008,629275,838Feb 04, 2021, 08:42 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerJan 28, 2021 Option Exercise$8.8075,000660,000251,257Jan 29, 2021, 06:10 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerJan 28, 2021 Sale$18.6275,0001,396,500176,257Jan 29, 2021, 06:10 PM
GREER R SCOTTDirectorJan 05, 2021 Option Exercise$13.8040,000552,000225,674Jan 05, 2021, 05:09 PM
Myriam CuretDirectorDec 15, 2020 Sale$17.821,56027,79919,240Dec 17, 2020, 06:08 PM
Zalevsky JonathanChief R&D OfficerNov 23, 2020 Sale$16.4016,380268,632250,317Nov 25, 2020, 06:09 PM
Zalevsky JonathanChief R&D OfficerNov 16, 2020 Sale$16.9329,618501,433266,697Nov 18, 2020, 07:08 PM
Wilson Mark AndrewSVP & General CounselNov 16, 2020 Sale$16.931,53926,05549,850Nov 18, 2020, 07:07 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerNov 16, 2020 Sale$16.9311,976202,754159,757Nov 18, 2020, 07:05 PM
ROBIN HOWARD WPresident & CEONov 16, 2020 Sale$16.9311,975202,737352,043Nov 18, 2020, 07:04 PM
Labrucherie Gil MSVP, COO & CFONov 16, 2020 Sale$16.938,276140,113226,973Nov 18, 2020, 07:03 PM
Ajer Jeffrey RobertDirectorSep 28, 2020 Sale$17.253,25056,06325,975Sep 30, 2020, 07:03 PM
CHESS ROBERTDirectorSep 25, 2020 Sale$17.755,50097,625280,573Sep 25, 2020, 08:16 PM
Labrucherie Gil MSVP, COO & CFOSep 17, 2020 Sale$19.962,00039,920235,249Sep 21, 2020, 08:59 PM
Ajer Jeffrey RobertDirectorSep 21, 2020 Sale$19.742,25044,41520,125Sep 21, 2020, 08:58 PM
CHESS ROBERTDirectorSep 08, 2020 Option Exercise$9.248,00073,920284,973Sep 10, 2020, 08:19 PM
CHESS ROBERTDirectorSep 08, 2020 Sale$18.538,000148,240276,973Sep 10, 2020, 08:19 PM
WHITFIELD ROY ADirectorSep 04, 2020 Option Exercise$9.2430,000277,200228,250Sep 08, 2020, 06:18 PM
Zalevsky JonathanChief R&D OfficerAug 17, 2020 Sale$19.6726,200515,354296,315Aug 19, 2020, 06:41 PM
Wilson Mark AndrewSVP & General CounselAug 17, 2020 Sale$19.671,52930,07551,389Aug 19, 2020, 06:40 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerAug 17, 2020 Sale$19.671,36726,889171,733Aug 19, 2020, 06:39 PM
ROBIN HOWARD WPresident & CEOAug 17, 2020 Sale$19.6711,885233,778364,018Aug 19, 2020, 06:38 PM
Labrucherie Gil MSVP, COO & CFOAug 18, 2020 Sale$19.682,00039,360237,249Aug 19, 2020, 06:37 PM
Labrucherie Gil MSVP, COO & CFOAug 17, 2020 Sale$19.676,245122,839239,249Aug 19, 2020, 06:37 PM
GREER R SCOTTDirectorJul 09, 2020 Option Exercise$9.2440,000369,600191,583Jul 10, 2020, 07:06 PM
GREER R SCOTTDirectorJul 09, 2020 Sale$25.0015,009375,225176,574Jul 10, 2020, 07:06 PM
CHESS ROBERTDirectorJul 08, 2020 Option Exercise$9.248,00073,920284,973Jul 10, 2020, 07:05 PM
CHESS ROBERTDirectorJul 08, 2020 Sale$24.588,000196,640276,973Jul 10, 2020, 07:05 PM
Zalevsky JonathanChief R&D OfficerMay 18, 2020 Sale$22.514,558102,601322,515May 20, 2020, 06:33 PM
Wilson Mark AndrewSVP & General CounselMay 18, 2020 Sale$22.511,52934,41852,418May 20, 2020, 06:32 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerMay 18, 2020 Sale$22.511,36730,771172,719May 20, 2020, 06:31 PM
ROBIN HOWARD WPresident & CEOMay 18, 2020 Sale$22.518,968201,870375,903May 20, 2020, 06:30 PM
Labrucherie Gil MSVP, COO & CFOMay 18, 2020 Sale$22.515,727128,915247,494May 20, 2020, 06:29 PM
Labrucherie Gil MSVP, COO & CFOMay 19, 2020 Sale$22.622,00045,240245,494May 20, 2020, 06:29 PM
CHESS ROBERTDirectorApr 15, 2020 Option Exercise$9.248,00073,920284,973Apr 17, 2020, 06:03 PM
CHESS ROBERTDirectorApr 15, 2020 Sale$18.388,000147,010277,170Apr 17, 2020, 06:03 PM
CHESS ROBERTDirectorMar 11, 2020 Option Exercise$9.248,00073,920284,973Mar 13, 2020, 06:04 PM
CHESS ROBERTDirectorMar 11, 2020 Sale$16.798,000134,316278,173Mar 13, 2020, 06:04 PM
Zalevsky JonathanChief R&D OfficerFeb 18, 2020 Sale$22.354,774106,699327,073Feb 20, 2020, 06:39 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 18, 2020 Sale$22.351,39431,156174,086Feb 20, 2020, 06:39 PM
ROBIN HOWARD WPresident & CEOFeb 18, 2020 Sale$22.358,448188,813384,871Feb 20, 2020, 06:38 PM
Labrucherie Gil MSVP, COO & CFOFeb 18, 2020 Sale$22.355,938132,714253,221Feb 20, 2020, 06:37 PM
CHESS ROBERTDirectorFeb 12, 2020 Option Exercise$9.248,00073,920284,973Feb 14, 2020, 07:00 PM
CHESS ROBERTDirectorFeb 12, 2020 Sale$23.508,000188,000280,572Feb 14, 2020, 07:00 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 06, 2020 Option Exercise$7.2137,500270,375212,980Feb 07, 2020, 07:31 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 06, 2020 Sale$22.7837,500854,250175,480Feb 07, 2020, 07:31 PM
WHITFIELD ROY ADirectorDec 18, 2019 Option Exercise$9.2410,00092,400198,250Dec 20, 2019, 06:31 PM
Zalevsky JonathanChief R&D OfficerNov 18, 2019 Sale$17.973,96071,161291,697Nov 20, 2019, 07:07 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerNov 18, 2019 Sale$17.972,71348,753160,441Nov 20, 2019, 07:06 PM
ROBIN HOWARD WPresident & CEONov 18, 2019 Sale$17.9713,556243,601299,219Nov 20, 2019, 07:05 PM
Labrucherie Gil MSVP, COO & CFONov 18, 2019 Sale$17.978,863159,268219,009Nov 20, 2019, 07:04 PM
Labrucherie Gil MSVP, COO & CFONov 13, 2019 Option Exercise$7.2125,000180,250252,872Nov 15, 2019, 06:09 PM
Labrucherie Gil MSVP, COO & CFONov 13, 2019 Sale$19.7925,000494,750227,872Nov 15, 2019, 06:09 PM
ROBIN HOWARD WPresident & CEOOct 15, 2019 Option Exercise$7.2133,333240,331346,108Oct 17, 2019, 07:00 PM
ROBIN HOWARD WPresident & CEOOct 17, 2019 Option Exercise$7.2133,333240,331346,108Oct 17, 2019, 07:00 PM
ROBIN HOWARD WPresident & CEOOct 16, 2019 Option Exercise$7.2133,334240,338346,109Oct 17, 2019, 07:00 PM
ROBIN HOWARD WPresident & CEOOct 17, 2019 Sale$17.6833,333589,327312,775Oct 17, 2019, 07:00 PM
ROBIN HOWARD WPresident & CEOOct 16, 2019 Sale$17.4833,334582,678312,775Oct 17, 2019, 07:00 PM
ROBIN HOWARD WPresident & CEOOct 15, 2019 Sale$16.9533,333565,085337,275Oct 17, 2019, 07:00 PM
Labrucherie Gil MSVP, COO & CFOOct 15, 2019 Option Exercise$7.2125,000180,250252,872Oct 17, 2019, 06:59 PM
Labrucherie Gil MSVP, COO & CFOOct 15, 2019 Sale$15.8325,000395,750227,872Oct 17, 2019, 06:59 PM
Lingnau LutzDirectorSep 27, 2019 Sale$17.843,00053,52026,700Oct 02, 2019, 07:51 PM
Ajer Jeffrey RobertDirectorSep 30, 2019 Sale$18.062,37542,89222,375Oct 01, 2019, 07:16 PM
CHESS ROBERTDirectorSep 27, 2019 Sale$17.994,00071,960276,973Oct 01, 2019, 07:15 PM
Ajer Jeffrey RobertDirectorSep 20, 2019 Sale$20.242,25045,54018,250Sep 24, 2019, 06:07 PM
Labrucherie Gil MSVP & Chief Financial OfficerSep 16, 2019 Option Exercise$7.2125,000180,250177,872Sep 18, 2019, 07:07 PM
Labrucherie Gil MSVP & Chief Financial OfficerSep 16, 2019 Sale$20.5225,000513,000152,872Sep 18, 2019, 07:07 PM
Doberstein Stephen KSVP & Chief Scientific OfficerSep 05, 2019 Buy$17.2815,000259,200107,668Sep 09, 2019, 05:09 PM
Labrucherie Gil MSVP & Chief Financial OfficerAug 26, 2019 Option Exercise$16.3130,000489,300152,872Aug 27, 2019, 05:20 PM
ROBIN HOWARD WPresident & CEOAug 23, 2019 Option Exercise$16.3130,000489,300312,775Aug 26, 2019, 05:21 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerAug 16, 2019 Sale$18.151,80932,833163,154Aug 19, 2019, 07:09 PM
ROBIN HOWARD WPresident & CEOAug 16, 2019 Sale$18.1512,551227,801282,775Aug 19, 2019, 07:08 PM
Nicholson JohnSVP & Chief Operating OfficerAug 16, 2019 Sale$18.153,81969,315162,759Aug 19, 2019, 07:07 PM
Labrucherie Gil MSVP & Chief Financial OfficerAug 16, 2019 Sale$18.155,06391,893122,872Aug 19, 2019, 07:07 PM
Doberstein Stephen KSVP & Chief Scientific OfficerAug 16, 2019 Sale$18.153,24558,89792,668Aug 19, 2019, 07:06 PM
Labrucherie Gil MSVP & Chief Financial OfficerAug 14, 2019 Option Exercise$7.2125,000180,250152,935Aug 16, 2019, 08:13 PM
Labrucherie Gil MSVP & Chief Financial OfficerAug 14, 2019 Sale$17.7925,000444,750127,935Aug 16, 2019, 08:13 PM
ROBIN HOWARD WPresident & CEOJul 24, 2019 Option Exercise$7.2133,334240,338328,660Jul 25, 2019, 08:02 PM
ROBIN HOWARD WPresident & CEOJul 23, 2019 Option Exercise$7.2133,333240,331328,659Jul 25, 2019, 08:02 PM
ROBIN HOWARD WPresident & CEOJul 25, 2019 Option Exercise$7.2133,333240,331328,659Jul 25, 2019, 08:02 PM
ROBIN HOWARD WPresident & CEOJul 24, 2019 Sale$32.1133,3341,070,355295,326Jul 25, 2019, 08:02 PM
ROBIN HOWARD WPresident & CEOJul 23, 2019 Sale$32.1033,3331,069,989295,326Jul 25, 2019, 08:02 PM
ROBIN HOWARD WPresident & CEOJul 25, 2019 Sale$29.6533,333988,323295,326Jul 25, 2019, 08:02 PM
Labrucherie Gil MSVP & Chief Financial OfficerJul 10, 2019 Option Exercise$7.2125,000180,250152,935Jul 12, 2019, 06:31 PM
Labrucherie Gil MSVP & Chief Financial OfficerJul 10, 2019 Sale$34.5725,000864,250127,935Jul 12, 2019, 06:31 PM
Lingnau LutzDirectorJul 08, 2019 Option Exercise$9.2410,00092,40033,200Jul 10, 2019, 05:34 PM
Lingnau LutzDirectorJul 08, 2019 Sale$34.6310,000346,30023,200Jul 10, 2019, 05:34 PM
Labrucherie Gil MSVP & Chief Financial OfficerJun 17, 2019 Option Exercise$7.2125,000180,250152,935Jun 19, 2019, 05:50 PM
Labrucherie Gil MSVP & Chief Financial OfficerJun 17, 2019 Sale$33.7125,000842,750127,935Jun 19, 2019, 05:50 PM
ROBIN HOWARD WPresident & CEOMay 22, 2019 Option Exercise$7.2133,334240,338328,660May 23, 2019, 07:19 PM
ROBIN HOWARD WPresident & CEOMay 21, 2019 Option Exercise$7.2133,333240,331328,659May 23, 2019, 07:19 PM
ROBIN HOWARD WPresident & CEOMay 23, 2019 Option Exercise$7.2133,333240,331328,659May 23, 2019, 07:19 PM
ROBIN HOWARD WPresident & CEOMay 21, 2019 Sale$32.9333,3331,097,656295,326May 23, 2019, 07:19 PM
ROBIN HOWARD WPresident & CEOMay 23, 2019 Sale$32.6933,3331,089,656295,326May 23, 2019, 07:19 PM
ROBIN HOWARD WPresident & CEOMay 22, 2019 Sale$33.3833,3341,112,689295,326May 23, 2019, 07:19 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerMay 16, 2019 Sale$31.371,92860,481164,463May 17, 2019, 08:22 PM
ROBIN HOWARD WPresident & CEOMay 16, 2019 Sale$31.3713,383419,825295,326May 17, 2019, 08:22 PM
Nicholson JohnSVP & Chief Operating OfficerMay 16, 2019 Sale$31.374,077127,895166,578May 17, 2019, 08:21 PM
Labrucherie Gil MSVP & Chief Financial OfficerMay 16, 2019 Sale$31.373,767118,171127,935May 17, 2019, 08:20 PM
Hora ManinderSVP Pharma Dev & Mfg OpsMay 16, 2019 Sale$31.372,44976,82594,694May 17, 2019, 08:19 PM
Doberstein Stephen KSVP & Chief Scientific OfficerMay 16, 2019 Sale$31.373,461108,57295,913May 17, 2019, 08:18 PM
GREER R SCOTTDirectorMar 08, 2019 Option Exercise$5.1410,00051,400145,083Mar 12, 2019, 06:18 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 19, 2019 Sale$42.391,80876,641166,391Feb 21, 2019, 08:17 PM
ROBIN HOWARD WPresident & CEOFeb 20, 2019 Option Exercise$7.2133,334240,338342,043Feb 21, 2019, 08:16 PM
ROBIN HOWARD WPresident & CEOFeb 19, 2019 Option Exercise$7.2133,333240,331350,924Feb 21, 2019, 08:16 PM
ROBIN HOWARD WPresident & CEOFeb 21, 2019 Option Exercise$7.2133,333240,331342,042Feb 21, 2019, 08:16 PM
ROBIN HOWARD WPresident & CEOFeb 20, 2019 Sale$43.2033,3341,440,029308,709Feb 21, 2019, 08:16 PM
ROBIN HOWARD WPresident & CEOFeb 19, 2019 Sale$42.3342,2151,787,161317,591Feb 21, 2019, 08:16 PM
ROBIN HOWARD WPresident & CEOFeb 21, 2019 Sale$41.0133,3331,366,986308,709Feb 21, 2019, 08:16 PM
Nicholson JohnSVP & Chief Operating OfficerFeb 19, 2019 Sale$42.393,822162,015170,655Feb 21, 2019, 08:15 PM
Labrucherie Gil MSVP & Chief Financial OfficerFeb 19, 2019 Sale$42.393,592152,265131,702Feb 21, 2019, 08:14 PM
Hora ManinderSVP Pharma Dev & Mfg OpsFeb 19, 2019 Sale$42.392,386101,14397,143Feb 21, 2019, 08:13 PM
Doberstein Stephen KSVP & Chief Scientific OfficerFeb 19, 2019 Sale$42.393,310140,31199,374Feb 21, 2019, 08:13 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 04, 2019 Option Exercise$10.6916,119172,312184,318Feb 06, 2019, 07:17 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 04, 2019 Sale$42.1616,119679,577168,199Feb 06, 2019, 07:17 PM
Nicholson JohnSVP & Chief Operating OfficerJan 28, 2019 Option Exercise$10.6963,000673,470237,477Jan 30, 2019, 06:02 PM
Nicholson JohnSVP & Chief Operating OfficerJan 28, 2019 Sale$42.8263,0002,697,660174,477Jan 30, 2019, 06:02 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerNov 16, 2018 Sale$38.254,016153,612157,249Nov 19, 2018, 06:15 PM
ROBIN HOWARD WPresident & CEONov 16, 2018 Sale$38.2515,326586,220249,141Nov 19, 2018, 06:14 PM
Nicholson JohnSVP & Chief Operating OfficerNov 16, 2018 Sale$38.255,982228,812174,477Nov 19, 2018, 06:14 PM
Labrucherie Gil MSVP & Chief Financial OfficerNov 16, 2018 Sale$38.256,515249,199106,544Nov 19, 2018, 06:13 PM
Hora ManinderSVP Pharma Dev & Mfg OpsNov 16, 2018 Sale$38.254,694179,54681,029Nov 19, 2018, 06:12 PM
Doberstein Stephen KSVP & Chief Scientific OfficerNov 16, 2018 Sale$38.254,524173,04378,734Nov 19, 2018, 06:11 PM
Lingnau LutzDirectorSep 20, 2018 Sale$56.989,000512,82018,450Sep 21, 2018, 07:32 PM
CHESS ROBERTDirectorSep 19, 2018 Sale$56.814,500255,645269,723Sep 21, 2018, 07:31 PM
Ajer Jeffrey RobertDirectorSep 20, 2018 Sale$56.766,750383,13015,750Sep 21, 2018, 07:29 PM
GREER R SCOTTDirectorSep 04, 2018 Option Exercise$5.1410,00051,400140,333Sep 06, 2018, 07:12 PM
GREER R SCOTTDirectorSep 04, 2018 Sale$67.3910,000673,900130,333Sep 06, 2018, 07:12 PM
WINGER DENNIS LDirectorAug 17, 2018 Option Exercise$14.2615,000213,90057,750Aug 21, 2018, 07:32 PM
WINGER DENNIS LDirectorAug 21, 2018 Option Exercise$14.2615,000213,90057,750Aug 21, 2018, 07:32 PM
WINGER DENNIS LDirectorAug 21, 2018 Sale$60.3015,000904,50042,750Aug 21, 2018, 07:32 PM
WINGER DENNIS LDirectorAug 17, 2018 Sale$59.6215,000894,30042,750Aug 21, 2018, 07:32 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerAug 16, 2018 Option Exercise$58.404,883285,16771,265Aug 16, 2018, 09:47 PM
Nicholson JohnSVP & Chief Operating OfficerAug 16, 2018 Option Exercise$58.408,137475,201180,459Aug 16, 2018, 09:46 PM
Labrucherie Gil MSVP & Chief Financial OfficerAug 16, 2018 Option Exercise$58.408,207479,289113,059Aug 16, 2018, 09:45 PM
Hora ManinderSVP Pharma Dev & Mfg OpsAug 16, 2018 Option Exercise$58.405,946347,24685,723Aug 16, 2018, 09:44 PM
ROBIN HOWARD WPresident & CEOAug 14, 2018 Option Exercise$10.6940,000427,600264,356Aug 16, 2018, 09:44 PM
ROBIN HOWARD WPresident & CEOAug 16, 2018 Option Exercise$58.4020,3891,190,718264,467Aug 16, 2018, 09:44 PM
ROBIN HOWARD WPresident & CEOAug 14, 2018 Option Exercise$60.0840,0002,403,200224,356Aug 16, 2018, 09:44 PM
Doberstein Stephen KSVP & Chief Scientific OfficerAug 16, 2018 Option Exercise$58.406,701391,33883,258Aug 16, 2018, 09:43 PM
WINGER DENNIS LDirectorAug 14, 2018 Sale$60.1517,1251,030,06942,750Aug 15, 2018, 07:30 PM
WINGER DENNIS LDirectorAug 13, 2018 Sale$61.0417,1251,045,31059,875Aug 15, 2018, 07:30 PM
ROBIN HOWARD WPresident & CEOJun 26, 2018 Option Exercise$10.6943,333463,230267,689Jun 27, 2018, 07:42 PM
ROBIN HOWARD WPresident & CEOJun 25, 2018 Option Exercise$10.6943,334463,240267,690Jun 27, 2018, 07:42 PM
ROBIN HOWARD WPresident & CEOJun 27, 2018 Option Exercise$10.6943,333463,230267,689Jun 27, 2018, 07:42 PM
ROBIN HOWARD WPresident & CEOJun 26, 2018 Sale$49.3643,3332,138,917224,356Jun 27, 2018, 07:42 PM
ROBIN HOWARD WPresident & CEOJun 25, 2018 Sale$51.8243,3342,245,568224,356Jun 27, 2018, 07:42 PM
ROBIN HOWARD WPresident & CEOJun 27, 2018 Sale$47.3943,3332,053,551224,356Jun 27, 2018, 07:42 PM
WHITFIELD ROY ADirectorJun 06, 2018 Buy$59.373,400201,860177,000Jun 07, 2018, 07:40 PM
WHITFIELD ROY ADirectorJun 05, 2018 Buy$55.221,60088,352173,600Jun 07, 2018, 07:40 PM
CHESS ROBERTDirectorJun 05, 2018 Option Exercise$14.2610,000142,600284,223Jun 07, 2018, 07:39 PM
CHESS ROBERTDirectorJun 05, 2018 Sale$55.1610,000551,600274,223Jun 07, 2018, 07:39 PM
GREER R SCOTTDirectorJun 06, 2018 Option Exercise$5.148,60044,204138,933Jun 06, 2018, 07:42 PM
GREER R SCOTTDirectorJun 04, 2018 Option Exercise$5.141,4007,196131,733Jun 06, 2018, 07:42 PM
GREER R SCOTTDirectorJun 06, 2018 Sale$60.008,600516,000130,333Jun 06, 2018, 07:42 PM
GREER R SCOTTDirectorJun 04, 2018 Sale$61.991,40086,786130,333Jun 06, 2018, 07:42 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerMay 16, 2018 Sale$83.393,576298,20365,281May 18, 2018, 07:07 PM
ROBIN HOWARD WPresident & CEOMay 16, 2018 Sale$83.3912,7911,066,641224,356May 18, 2018, 07:06 PM
Nicholson JohnSVP & Chief Operating OfficerMay 16, 2018 Sale$83.394,917410,029162,596May 18, 2018, 07:05 PM
Labrucherie Gil MSVP & Chief Financial OfficerMay 16, 2018 Sale$83.394,941412,03094,798May 18, 2018, 07:03 PM
Hora ManinderSVP Pharma Dev & Mfg OpsMay 16, 2018 Sale$83.394,060338,56376,201May 18, 2018, 07:02 PM
Doberstein Stephen KSVP & Chief Scientific OfficerMay 16, 2018 Sale$83.393,435286,44563,959May 18, 2018, 07:01 PM
CHESS ROBERTDirectorMay 03, 2018 Option Exercise$8.7925,000219,700289,223May 04, 2018, 06:55 PM
CHESS ROBERTDirectorMay 03, 2018 Sale$82.8025,0002,070,050274,223May 04, 2018, 06:55 PM
Labrucherie Gil MSVP & Chief Financial OfficerMay 03, 2018 Option Exercise$10.6930,000320,700129,739May 03, 2018, 08:43 PM
Labrucherie Gil MSVP & Chief Financial OfficerMay 02, 2018 Option Exercise$10.6930,000320,700129,739May 03, 2018, 08:43 PM
Labrucherie Gil MSVP & Chief Financial OfficerMay 01, 2018 Option Exercise$10.6930,000320,700129,739May 03, 2018, 08:43 PM
Labrucherie Gil MSVP & Chief Financial OfficerMay 03, 2018 Sale$82.8630,0002,485,80099,739May 03, 2018, 08:43 PM
Labrucherie Gil MSVP & Chief Financial OfficerMay 02, 2018 Sale$85.6330,0002,568,90099,739May 03, 2018, 08:43 PM
Labrucherie Gil MSVP & Chief Financial OfficerMay 01, 2018 Sale$83.6530,0002,509,50099,739May 03, 2018, 08:43 PM
ROBIN HOWARD WPresident & CEOMay 03, 2018 Option Exercise$10.6943,333463,230280,480May 03, 2018, 08:42 PM
ROBIN HOWARD WPresident & CEOMay 02, 2018 Option Exercise$10.6943,333463,230280,480May 03, 2018, 08:42 PM
ROBIN HOWARD WPresident & CEOMay 01, 2018 Option Exercise$10.6943,334463,240280,481May 03, 2018, 08:42 PM
ROBIN HOWARD WPresident & CEOMay 03, 2018 Sale$82.8643,3333,590,572237,147May 03, 2018, 08:42 PM
ROBIN HOWARD WPresident & CEOMay 02, 2018 Sale$85.6343,3333,710,605237,147May 03, 2018, 08:42 PM
ROBIN HOWARD WPresident & CEOMay 01, 2018 Sale$83.6543,3343,624,889237,147May 03, 2018, 08:42 PM
WHITFIELD ROY ADirectorApr 17, 2018 Option Exercise$14.2630,000427,800172,000Apr 18, 2018, 06:05 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerApr 16, 2018 Option Exercise$10.6913,881148,38882,738Apr 18, 2018, 06:03 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerApr 16, 2018 Sale$101.4613,8811,408,36668,857Apr 18, 2018, 06:03 PM
Hora ManinderSVP Pharma Dev & Mfg OpsApr 10, 2018 Option Exercise$7.215023,61980,763Apr 12, 2018, 06:05 PM
Hora ManinderSVP Pharma Dev & Mfg OpsApr 10, 2018 Sale$105.6750253,04680,261Apr 12, 2018, 06:05 PM
Lingnau LutzDirectorApr 05, 2018 Option Exercise$9.2430,000277,20057,450Apr 09, 2018, 08:23 PM
Lingnau LutzDirectorApr 05, 2018 Sale$101.7430,0003,052,20027,450Apr 09, 2018, 08:23 PM
Hora ManinderSVP Pharma Dev & Mfg OpsApr 09, 2018 Option Exercise$7.219,49868,48189,759Apr 09, 2018, 08:22 PM
Hora ManinderSVP Pharma Dev & Mfg OpsApr 05, 2018 Option Exercise$7.2120,000144,200100,261Apr 09, 2018, 08:22 PM
Hora ManinderSVP Pharma Dev & Mfg OpsApr 09, 2018 Sale$105.059,498997,76580,261Apr 09, 2018, 08:22 PM
Hora ManinderSVP Pharma Dev & Mfg OpsApr 05, 2018 Sale$101.7520,0002,035,00080,261Apr 09, 2018, 08:22 PM
GREER R SCOTTDirectorApr 06, 2018 Option Exercise$14.2630,000427,800160,333Apr 09, 2018, 08:22 PM
GREER R SCOTTDirectorApr 06, 2018 Sale$92.2230,0002,766,600130,333Apr 09, 2018, 08:22 PM
Doberstein Stephen KSVP & Chief Scientific OfficerApr 09, 2018 Option Exercise$7.2149,500356,895116,894Apr 09, 2018, 08:21 PM
Doberstein Stephen KSVP & Chief Scientific OfficerApr 06, 2018 Option Exercise$9.10110,5001,005,505177,894Apr 09, 2018, 08:21 PM
Doberstein Stephen KSVP & Chief Scientific OfficerApr 09, 2018 Sale$96.1349,5004,758,43567,394Apr 09, 2018, 08:21 PM
Doberstein Stephen KSVP & Chief Scientific OfficerApr 06, 2018 Sale$91.69110,50010,131,74567,394Apr 09, 2018, 08:21 PM
CHESS ROBERTDirectorApr 06, 2018 Option Exercise$8.7925,000219,700289,223Apr 09, 2018, 08:20 PM
CHESS ROBERTDirectorApr 06, 2018 Sale$92.1425,0002,303,600274,223Apr 09, 2018, 08:20 PM
KUEBLER CHRISTOPHER ADirectorMar 07, 2018 Option Exercise$6.2437,400233,23677,900Mar 08, 2018, 06:10 PM
KUEBLER CHRISTOPHER ADirectorMar 06, 2018 Option Exercise$5.142,60013,36443,100Mar 08, 2018, 06:10 PM
KUEBLER CHRISTOPHER ADirectorMar 06, 2018 Sale$100.302,600260,78040,500Mar 08, 2018, 06:10 PM
KUEBLER CHRISTOPHER ADirectorMar 07, 2018 Sale$97.4137,4003,643,13440,500Mar 08, 2018, 06:10 PM
Nicholson JohnSVP & Chief Operating OfficerMar 07, 2018 Sale$100.45100,14410,059,464167,513Mar 08, 2018, 06:09 PM
Nicholson JohnSVP & Chief Operating OfficerMar 06, 2018 Sale$98.29120,00011,794,800267,657Mar 08, 2018, 06:09 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 16, 2018 Sale$82.942,545211,08268,857Feb 20, 2018, 07:10 PM
ROBIN HOWARD WPresident & CEOFeb 16, 2018 Sale$82.9412,7881,060,637237,147Feb 20, 2018, 07:10 PM
Nicholson JohnSVP & Chief Operating OfficerFeb 16, 2018 Sale$82.944,879404,664387,657Feb 20, 2018, 07:09 PM
Labrucherie Gil MSVP & Chief Financial OfficerFeb 16, 2018 Sale$82.943,477288,38299,739Feb 20, 2018, 07:08 PM
Hora ManinderSVP Pharma Dev & Mfg OpsFeb 16, 2018 Sale$82.942,875238,45380,261Feb 20, 2018, 07:07 PM
Doberstein Stephen KSVP & Chief Scientific OfficerFeb 16, 2018 Sale$82.942,426201,21267,394Feb 20, 2018, 07:07 PM
Nicholson JohnSVP & Chief Operating OfficerJan 31, 2018 Option Exercise$11.34120,0001,360,800392,536Feb 02, 2018, 06:03 PM
ROBIN HOWARD WPresident & CEOJan 22, 2018 Option Exercise$11.3483,333944,996333,268Jan 24, 2018, 06:01 PM
ROBIN HOWARD WPresident & CEOJan 22, 2018 Sale$75.8283,3336,318,308249,935Jan 24, 2018, 06:01 PM
WINGER DENNIS LDirectorJan 04, 2018 Option Exercise$11.9733,750403,98877,000Jan 08, 2018, 06:07 PM
KUEBLER CHRISTOPHER ADirectorJan 02, 2018 Option Exercise$14.2630,000427,80070,500Jan 04, 2018, 06:01 PM
KUEBLER CHRISTOPHER ADirectorJan 02, 2018 Sale$58.6630,0001,759,80040,500Jan 04, 2018, 06:01 PM
ROBIN HOWARD WPresident & CEODec 13, 2017 Option Exercise$11.3483,333944,996272,768Dec 15, 2017, 06:00 PM
ROBIN HOWARD WPresident & CEODec 13, 2017 Sale$55.6983,3334,640,815189,435Dec 15, 2017, 06:00 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerNov 16, 2017 Option Exercise$44.235,289233,93260,549Nov 17, 2017, 06:06 PM
ROBIN HOWARD WPresident & CEONov 16, 2017 Option Exercise$44.2318,069799,192189,435Nov 17, 2017, 06:06 PM
Nicholson JohnSVP & Chief Operating OfficerNov 16, 2017 Option Exercise$44.236,620292,803246,536Nov 17, 2017, 06:05 PM
Labrucherie Gil MSVP & Chief Financial OfficerNov 16, 2017 Option Exercise$44.236,698296,25376,716Nov 17, 2017, 06:05 PM
Hora ManinderSVP Pharma Dev & Mfg OpsNov 16, 2017 Option Exercise$44.235,597247,55567,636Nov 17, 2017, 06:04 PM
Gergel Ivan P.SVP & Chief Medical OfficerNov 16, 2017 Option Exercise$44.235,022222,12356,553Nov 17, 2017, 06:03 PM
Doberstein Stephen KSVP & Chief Scientific OfficerNov 16, 2017 Option Exercise$44.234,782211,50843,820Nov 17, 2017, 06:03 PM
Nicholson JohnSVP & Chief Operating OfficerNov 13, 2017 Option Exercise$9.2425,000231,000249,066Nov 15, 2017, 06:02 PM
Nicholson JohnSVP & Chief Operating OfficerNov 13, 2017 Sale$37.7815,910601,080233,156Nov 15, 2017, 06:02 PM
Hora ManinderSVP Pharma Dev & Mfg OpsNov 07, 2017 Option Exercise$18.1034,600626,26075,533Nov 08, 2017, 06:02 PM
Hora ManinderSVP Pharma Dev & Mfg OpsNov 06, 2017 Option Exercise$10.695,11754,70163,350Nov 08, 2017, 06:02 PM
Hora ManinderSVP Pharma Dev & Mfg OpsNov 06, 2017 Sale$25.075,117128,28358,233Nov 08, 2017, 06:02 PM
Doberstein Stephen KSVP & Chief Scientific OfficerNov 06, 2017 Option Exercise$9.5320,914199,31052,016Nov 08, 2017, 06:01 PM
Doberstein Stephen KSVP & Chief Scientific OfficerNov 08, 2017 Option Exercise$9.53300,0002,859,000331,102Nov 08, 2017, 06:01 PM
Doberstein Stephen KSVP & Chief Scientific OfficerNov 07, 2017 Option Exercise$9.5375,409718,648106,511Nov 08, 2017, 06:01 PM
Doberstein Stephen KSVP & Chief Scientific OfficerNov 06, 2017 Sale$24.9820,914522,43231,102Nov 08, 2017, 06:01 PM
Doberstein Stephen KSVP & Chief Scientific OfficerNov 08, 2017 Sale$30.09300,0009,027,00031,102Nov 08, 2017, 06:01 PM
Doberstein Stephen KSVP & Chief Scientific OfficerNov 07, 2017 Sale$25.7875,4091,944,04431,102Nov 08, 2017, 06:01 PM
ROBIN HOWARD WPresident & CEONov 01, 2017 Option Exercise$11.3483,334945,008235,838Nov 03, 2017, 06:07 PM
ROBIN HOWARD WPresident & CEONov 01, 2017 Sale$23.5783,3341,964,182152,504Nov 03, 2017, 06:07 PM
ROBIN HOWARD WPresident & CEOOct 09, 2017 Option Exercise$11.3483,333944,996235,837Oct 10, 2017, 06:08 PM
ROBIN HOWARD WPresident & CEOOct 09, 2017 Sale$24.2083,3332,016,659152,504Oct 10, 2017, 06:08 PM
Hora ManinderSVP Pharma Dev & Mfg OpsOct 05, 2017 Option Exercise$10.697,58381,06265,816Oct 10, 2017, 06:07 PM
Hora ManinderSVP Pharma Dev & Mfg OpsOct 05, 2017 Sale$25.007,583189,57558,233Oct 10, 2017, 06:07 PM
Doberstein Stephen KSVP & Chief Scientific OfficerOct 05, 2017 Option Exercise$9.5343,677416,24274,779Oct 10, 2017, 06:06 PM
Doberstein Stephen KSVP & Chief Scientific OfficerOct 05, 2017 Sale$24.9743,6771,090,61531,102Oct 10, 2017, 06:06 PM
Labrucherie Gil MSVP & Chief Financial OfficerOct 02, 2017 Option Exercise$11.34120,0001,360,800183,414Oct 03, 2017, 06:06 PM
Labrucherie Gil MSVP & Chief Financial OfficerOct 02, 2017 Sale$24.45120,0002,934,00063,414Oct 03, 2017, 06:06 PM
Gergel Ivan P.SVP & Chief Medical OfficerOct 02, 2017 Option Exercise$11.0456,704626,01298,279Oct 03, 2017, 06:02 PM
Gergel Ivan P.SVP & Chief Medical OfficerSep 29, 2017 Option Exercise$11.0443,296477,98884,871Oct 03, 2017, 06:02 PM
Gergel Ivan P.SVP & Chief Medical OfficerOct 02, 2017 Sale$24.2156,7041,372,80441,575Oct 03, 2017, 06:02 PM
Gergel Ivan P.SVP & Chief Medical OfficerSep 29, 2017 Sale$24.0443,2961,040,83641,575Oct 03, 2017, 06:02 PM
Lingnau LutzDirectorSep 22, 2017 Sale$21.975,000109,85027,450Sep 25, 2017, 06:04 PM
KUEBLER CHRISTOPHER ADirectorSep 22, 2017 Sale$21.864,00087,44040,500Sep 25, 2017, 06:03 PM
CHESS ROBERTDirectorSep 21, 2017 Sale$21.726,400139,008274,223Sep 25, 2017, 06:02 PM
ROBIN HOWARD WPresident & CEOSep 06, 2017 Option Exercise$11.3483,333944,996235,837Sep 08, 2017, 06:08 PM
ROBIN HOWARD WPresident & CEOSep 06, 2017 Sale$21.5483,3331,794,993152,504Sep 08, 2017, 06:08 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerAug 16, 2017 Sale$19.322,64851,15950,838Aug 18, 2017, 07:05 PM
ROBIN HOWARD WPresident & CEOAug 16, 2017 Option Exercise$11.3483,334945,008235,838Aug 18, 2017, 07:05 PM
ROBIN HOWARD WPresident & CEOAug 16, 2017 Sale$19.2691,7141,766,081152,504Aug 18, 2017, 07:05 PM
Nicholson JohnSVP & Chief Operating OfficerAug 16, 2017 Sale$19.323,17761,380224,066Aug 18, 2017, 07:04 PM
Labrucherie Gil MSVP & Chief Financial OfficerAug 16, 2017 Sale$19.323,17761,38063,414Aug 18, 2017, 07:04 PM
Hora ManinderSVP Pharma Dev & Mfg OpsAug 16, 2017 Sale$19.322,95657,11058,233Aug 18, 2017, 07:03 PM
Gergel Ivan P.SVP & Chief Medical OfficerAug 16, 2017 Sale$19.321,99738,58241,575Aug 18, 2017, 07:02 PM
Doberstein Stephen KSVP & Chief Scientific OfficerAug 16, 2017 Sale$19.321,70132,86331,102Aug 18, 2017, 07:01 PM
WHITFIELD ROY ADirectorAug 10, 2017 Buy$17.9535,000628,250133,000Aug 14, 2017, 09:07 AM
Gergel Ivan P.SVP & Chief Medical OfficerJul 18, 2017 Option Exercise$11.0454,920606,31798,492Jul 20, 2017, 05:08 PM
Gergel Ivan P.SVP & Chief Medical OfficerJul 18, 2017 Sale$21.1054,9201,158,81243,572Jul 20, 2017, 05:08 PM
Lingnau LutzDirectorJul 14, 2017 Option Exercise$14.2630,000427,80053,450Jul 18, 2017, 08:02 PM
Lingnau LutzDirectorJul 14, 2017 Sale$20.7630,000622,80023,450Jul 18, 2017, 08:02 PM
Gergel Ivan P.SVP & Chief Medical OfficerJul 11, 2017 Option Exercise$11.048,38992,61551,961Jul 13, 2017, 08:01 PM
Gergel Ivan P.SVP & Chief Medical OfficerJul 12, 2017 Option Exercise$11.0436,691405,06980,263Jul 13, 2017, 08:01 PM
Gergel Ivan P.SVP & Chief Medical OfficerJul 11, 2017 Sale$21.048,389176,50543,572Jul 13, 2017, 08:01 PM
Gergel Ivan P.SVP & Chief Medical OfficerJul 12, 2017 Sale$21.0936,691773,81343,572Jul 13, 2017, 08:01 PM
Krivulka Joseph JDirectorJun 26, 2017 Option Exercise$8.3715,000125,55073,000Jun 28, 2017, 06:05 PM
Nicholson JohnSVP & Chief Operating OfficerJun 07, 2017 Option Exercise$6.34150,000951,000328,943Jun 09, 2017, 06:02 PM
Nicholson JohnSVP & Chief Operating OfficerJun 07, 2017 Sale$19.24101,7001,956,708227,243Jun 09, 2017, 06:02 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerMay 16, 2017 Sale$19.552,65151,82752,986May 18, 2017, 08:50 PM
ROBIN HOWARD WPresident & CEOMay 16, 2017 Sale$19.558,388163,985160,884May 18, 2017, 08:50 PM
Nicholson JohnSVP & Chief Operating OfficerMay 16, 2017 Sale$19.553,14661,504178,943May 18, 2017, 08:49 PM
Labrucherie Gil MSVP & Chief Financial OfficerMay 16, 2017 Sale$19.553,17962,14966,091May 18, 2017, 08:48 PM
Hora ManinderSVP Pharma Dev & Mfg OpsMay 16, 2017 Sale$19.552,95957,84860,689May 18, 2017, 08:47 PM
Gergel Ivan P.SVP & Chief Medical OfficerMay 16, 2017 Sale$19.551,45028,34743,572May 18, 2017, 08:46 PM
Doberstein Stephen KSVP & Chief Scientific OfficerMay 16, 2017 Sale$19.551,70133,25532,803May 18, 2017, 08:45 PM
CHESS ROBERTDirectorMay 15, 2017 Option Exercise$8.375,00041,850276,623May 17, 2017, 06:02 PM
CHESS ROBERTDirectorMay 15, 2017 Sale$19.795,00098,950271,623May 17, 2017, 06:02 PM
CHESS ROBERTDirectorApr 17, 2017 Option Exercise$8.375,00041,850276,623Apr 19, 2017, 07:30 PM
CHESS ROBERTDirectorApr 17, 2017 Sale$18.725,00093,600271,623Apr 19, 2017, 07:30 PM
Lingnau LutzDirectorApr 07, 2017 Sale$20.057,000140,35023,450Apr 11, 2017, 06:04 PM
Doberstein Stephen KSVP & Chief Scientific OfficerApr 05, 2017 Option Exercise$9.53100,000953,000134,504Apr 07, 2017, 06:07 PM
Doberstein Stephen KSVP & Chief Scientific OfficerApr 05, 2017 Sale$21.70100,0002,170,00034,504Apr 07, 2017, 06:07 PM
Hora ManinderSVP Pharma Dev & Mfg OpsApr 05, 2017 Option Exercise$13.70180,0002,466,000243,648Apr 07, 2017, 06:05 PM
Hora ManinderSVP Pharma Dev & Mfg OpsApr 05, 2017 Sale$21.70180,0003,906,00063,648Apr 07, 2017, 06:05 PM
KUEBLER CHRISTOPHER ADirectorApr 05, 2017 Option Exercise$8.3715,000125,55050,500Apr 07, 2017, 06:01 PM
KUEBLER CHRISTOPHER ADirectorApr 05, 2017 Sale$21.8815,000328,20035,500Apr 07, 2017, 06:01 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerMar 20, 2017 Option Exercise$9.96112,5001,120,875168,137Mar 22, 2017, 06:04 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerMar 20, 2017 Sale$19.69112,5002,215,12555,637Mar 22, 2017, 06:04 PM
WHITFIELD ROY ADirectorMar 15, 2017 Option Exercise$8.3714,000117,18098,000Mar 17, 2017, 06:02 PM
CHESS ROBERTDirectorMar 14, 2017 Option Exercise$8.375,00041,850276,623Mar 16, 2017, 06:02 PM
CHESS ROBERTDirectorMar 14, 2017 Sale$15.415,00077,050271,623Mar 16, 2017, 06:02 PM
Labrucherie Gil MSVP & Chief Financial OfficerMar 03, 2017 Option Exercise$8.5732,494278,51294,270Mar 03, 2017, 07:04 PM
Labrucherie Gil MSVP & Chief Financial OfficerMar 02, 2017 Option Exercise$6.34167,5061,061,988236,776Mar 03, 2017, 07:04 PM
Labrucherie Gil MSVP & Chief Financial OfficerMar 03, 2017 Sale$15.2132,494494,23469,270Mar 03, 2017, 07:04 PM
Labrucherie Gil MSVP & Chief Financial OfficerMar 02, 2017 Sale$15.15167,5062,537,71669,270Mar 03, 2017, 07:04 PM
Lingnau LutzDirectorFeb 21, 2017 Option Exercise$5.1430,000154,20060,450Feb 23, 2017, 06:32 PM
Lingnau LutzDirectorFeb 21, 2017 Sale$13.0830,000392,40030,450Feb 23, 2017, 06:32 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 16, 2017 Sale$13.141,96525,82055,637Feb 17, 2017, 08:06 PM
ROBIN HOWARD WPresident & CEOFeb 16, 2017 Sale$13.148,636113,477169,272Feb 17, 2017, 08:06 PM
Nicholson JohnSVP & Chief Operating OfficerFeb 16, 2017 Sale$13.143,23742,534182,089Feb 17, 2017, 08:05 PM
Labrucherie Gil MSVP & Chief Financial OfficerFeb 16, 2017 Sale$13.142,35930,99769,270Feb 17, 2017, 08:04 PM
Hora ManinderSVP Pharma Dev & Mfg OpsFeb 16, 2017 Sale$13.142,19528,84263,648Feb 17, 2017, 08:04 PM
Gergel Ivan P.SVP & Chief Medical OfficerFeb 16, 2017 Sale$13.141,45719,14545,022Feb 17, 2017, 08:03 PM
Doberstein Stephen KSVP & Chief Scientific OfficerFeb 16, 2017 Sale$13.141,26116,57034,504Feb 17, 2017, 08:02 PM
Nicholson JohnSVP & Chief Operating OfficerFeb 10, 2017 Option Exercise$4.6545,000209,250185,326Feb 10, 2017, 08:11 PM
ROBIN HOWARD WPresident & CEOFeb 08, 2017 Option Exercise$4.6587,500406,875265,408Feb 10, 2017, 08:10 PM
ROBIN HOWARD WPresident & CEOFeb 08, 2017 Sale$13.0487,5001,141,000177,908Feb 10, 2017, 08:10 PM
Nicholson JohnSVP & Chief Operating OfficerFeb 02, 2017 Option Exercise$4.6566,495309,202206,821Feb 06, 2017, 05:20 PM
Nicholson JohnSVP & Chief Operating OfficerFeb 03, 2017 Option Exercise$4.658,50539,548148,831Feb 06, 2017, 05:20 PM
Nicholson JohnSVP & Chief Operating OfficerFeb 02, 2017 Sale$12.3866,495823,208140,326Feb 06, 2017, 05:20 PM
Nicholson JohnSVP & Chief Operating OfficerFeb 03, 2017 Sale$12.488,505106,142140,326Feb 06, 2017, 05:20 PM
ROBIN HOWARD WPresident & CEOJan 17, 2017 Option Exercise$4.6587,500406,875265,408Jan 19, 2017, 08:01 PM
ROBIN HOWARD WPresident & CEOJan 17, 2017 Sale$12.3587,5001,080,625177,908Jan 19, 2017, 08:01 PM
ROBIN HOWARD WPresident & CEODec 07, 2016 Option Exercise$4.6587,500406,875210,408Dec 09, 2016, 06:03 PM
ROBIN HOWARD WPresident & CEODec 07, 2016 Sale$12.2487,5001,071,000122,908Dec 09, 2016, 06:03 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerNov 16, 2016 Sale$13.961,98627,72542,102Nov 18, 2016, 06:12 PM
ROBIN HOWARD WPresident & CEONov 17, 2016 Option Exercise$4.6587,500406,875210,408Nov 18, 2016, 06:12 PM
ROBIN HOWARD WPresident & CEONov 17, 2016 Sale$13.8787,5001,213,625122,908Nov 18, 2016, 06:12 PM
ROBIN HOWARD WPresident & CEONov 16, 2016 Sale$13.965,95883,174122,908Nov 18, 2016, 06:12 PM
Nicholson JohnSVP & Chief Operating OfficerNov 16, 2016 Sale$13.961,65423,090120,326Nov 18, 2016, 06:11 PM
Labrucherie Gil MSVP & Chief Financial OfficerNov 16, 2016 Sale$13.961,65423,09051,129Nov 18, 2016, 06:10 PM
Hora ManinderSVP Pharma Dev & Mfg OpsNov 16, 2016 Sale$13.961,65423,09050,343Nov 18, 2016, 06:09 PM
Gergel Ivan P.SVP & Chief Medical OfficerNov 16, 2016 Sale$13.9684811,83826,479Nov 18, 2016, 06:08 PM
Doberstein Stephen KSVP & Chief Scientific OfficerNov 16, 2016 Sale$13.966709,35318,265Nov 18, 2016, 06:07 PM
GREER R SCOTTDirectorOct 24, 2016 Buy$13.5015,000202,500121,333Oct 25, 2016, 05:00 PM
ROBIN HOWARD WPresident & CEOOct 04, 2016 Option Exercise$4.6587,500406,875216,366Oct 06, 2016, 05:07 PM
ROBIN HOWARD WPresident & CEOOct 04, 2016 Sale$17.0687,5001,492,750128,866Oct 06, 2016, 05:07 PM
WHITFIELD ROY ADirectorSep 23, 2016 Option Exercise$5.2146,000239,82084,000Sep 27, 2016, 05:09 PM
Lingnau LutzDirectorSep 15, 2016 Sale$19.069,000171,5407,450Sep 19, 2016, 05:16 PM
KUEBLER CHRISTOPHER ADirectorSep 16, 2016 Sale$19.137,500143,47527,500Sep 19, 2016, 05:15 PM
CHESS ROBERTDirectorSep 15, 2016 Sale$19.2112,000230,520248,623Sep 19, 2016, 05:13 PM
ROBIN HOWARD WPresident & CEOSep 01, 2016 Option Exercise$4.6587,500406,875216,366Sep 02, 2016, 08:03 PM
ROBIN HOWARD WPresident & CEOSep 01, 2016 Sale$17.8387,5001,560,125128,886Sep 02, 2016, 08:03 PM
Nicholson JohnSVP & Chief Operating OfficerAug 16, 2016 Sale$17.563,31758,247121,980Aug 17, 2016, 05:45 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerAug 16, 2016 Sale$17.563,97169,73144,088Aug 17, 2016, 05:42 PM
ROBIN HOWARD WPresident & CEOAug 16, 2016 Sale$17.5611,817207,507128,866Aug 17, 2016, 05:41 PM
Labrucherie Gil MSVP & Chief Financial OfficerAug 16, 2016 Sale$17.563,30558,03652,783Aug 17, 2016, 05:39 PM
Hora ManinderSVP Pharma Dev & Mfg OpsAug 16, 2016 Sale$17.563,30558,03651,997Aug 17, 2016, 05:38 PM
Gergel Ivan P.SVP & Chief Medical OfficerAug 16, 2016 Sale$17.561,68529,58927,327Aug 17, 2016, 05:38 PM
Doberstein Stephen KSVP & Chief Scientific OfficerAug 16, 2016 Sale$17.561,33623,46018,935Aug 17, 2016, 05:37 PM
CHESS ROBERTDirectorAug 01, 2016 Option Exercise$5.155,00025,750265,623Aug 03, 2016, 07:01 PM
CHESS ROBERTDirectorAug 01, 2016 Sale$17.265,00086,300260,623Aug 03, 2016, 07:01 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerJul 11, 2016 Option Exercise$4.65100,000465,000106,809Jul 13, 2016, 05:08 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerJul 11, 2016 Sale$15.09100,0001,509,0006,809Jul 13, 2016, 05:08 PM
CHESS ROBERTDirectorJul 01, 2016 Option Exercise$5.155,00025,750265,623Jul 05, 2016, 05:21 PM
CHESS ROBERTDirectorJul 01, 2016 Sale$14.105,00070,500260,623Jul 05, 2016, 05:21 PM
CHESS ROBERTDirectorJun 01, 2016 Option Exercise$5.155,00025,750265,623Jun 03, 2016, 05:05 PM
CHESS ROBERTDirectorJun 01, 2016 Sale$15.505,00077,500260,623Jun 03, 2016, 05:05 PM
Nicholson JohnSVP & Chief Financial OfficerMay 16, 2016 Option Exercise$0.002,167078,486May 18, 2016, 05:23 PM
Nicholson JohnSVP & Chief Financial OfficerMay 17, 2016 Sale$13.5885611,62477,630May 18, 2016, 05:23 PM
ROBIN HOWARD WPresident & CEOMay 16, 2016 Option Exercise$0.005,625119,103May 18, 2016, 05:23 PM
ROBIN HOWARD WPresident & CEOMay 17, 2016 Sale$13.582,17029,46916,933May 18, 2016, 05:23 PM
Doberstein Stephen KSVP & Chief Scientific OfficerMay 16, 2016 Option Exercise$0.0087501,360May 18, 2016, 05:15 PM
Doberstein Stephen KSVP & Chief Scientific OfficerMay 17, 2016 Sale$13.583394,6041,021May 18, 2016, 05:15 PM
Gergel Ivan P.SVP & Chief Medical OfficerMay 16, 2016 Option Exercise$0.001,25001,944May 18, 2016, 05:14 PM
Gergel Ivan P.SVP & Chief Medical OfficerMay 17, 2016 Sale$13.584325,8671,512May 18, 2016, 05:14 PM
Hora ManinderSVP Pharma Dev & Mfg OpsMay 16, 2016 Option Exercise$0.002,16707,970May 18, 2016, 05:13 PM
Hora ManinderSVP Pharma Dev & Mfg OpsMay 17, 2016 Sale$13.5883511,3397,135May 18, 2016, 05:13 PM
Labrucherie Gil MSVP & General CounselMay 16, 2016 Option Exercise$0.002,16708,757May 18, 2016, 05:12 PM
Labrucherie Gil MSVP & General CounselMay 17, 2016 Sale$13.5883611,3537,921May 18, 2016, 05:12 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerMay 16, 2016 Option Exercise$0.001,87507,033May 18, 2016, 05:08 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerMay 17, 2016 Sale$13.587249,8326,309May 18, 2016, 05:08 PM
Lingnau LutzDirectorApr 25, 2016 Option Exercise$8.3715,000125,55031,450Apr 27, 2016, 05:08 PM
Lingnau LutzDirectorApr 25, 2016 Sale$16.2715,000244,05016,450Apr 27, 2016, 05:08 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerMar 09, 2016 Option Exercise$6.6515,00099,75020,158Mar 11, 2016, 05:06 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerMar 09, 2016 Sale$11.7915,000176,8505,158Mar 11, 2016, 05:06 PM
Gergel Ivan P.SVP & Chief Medical OfficerFeb 16, 2016 Option Exercise$0.001,25001,250Feb 18, 2016, 07:49 PM
Gergel Ivan P.SVP & Chief Medical OfficerFeb 17, 2016 Sale$11.925566,628694Feb 18, 2016, 07:49 PM
Nicholson JohnSVP & Chief Financial OfficerFeb 16, 2016 Option Exercise$0.002,166077,282Feb 18, 2016, 07:48 PM
Nicholson JohnSVP & Chief Financial OfficerFeb 17, 2016 Sale$11.9296311,47976,319Feb 18, 2016, 07:48 PM
ROBIN HOWARD WPresident & CEOFeb 16, 2016 Option Exercise$0.005,625115,625Feb 18, 2016, 07:48 PM
ROBIN HOWARD WPresident & CEOFeb 17, 2016 Sale$11.922,14725,59213,478Feb 18, 2016, 07:48 PM
Doberstein Stephen KSVP & Chief Scientific OfficerFeb 16, 2016 Option Exercise$0.008750875Feb 18, 2016, 07:47 PM
Doberstein Stephen KSVP & Chief Scientific OfficerFeb 17, 2016 Sale$11.923904,649485Feb 18, 2016, 07:47 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 16, 2016 Option Exercise$0.001,87505,874Feb 18, 2016, 07:46 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 17, 2016 Sale$11.927168,5355,158Feb 18, 2016, 07:46 PM
Labrucherie Gil MSVP & General CounselFeb 16, 2016 Option Exercise$0.002,16607,417Feb 18, 2016, 07:45 PM
Labrucherie Gil MSVP & General CounselFeb 17, 2016 Sale$11.928279,8586,590Feb 18, 2016, 07:45 PM
Hora ManinderSVP Pharma Dev & Mfg OpsFeb 16, 2016 Option Exercise$0.002,16606,766Feb 18, 2016, 07:45 PM
Hora ManinderSVP Pharma Dev & Mfg OpsFeb 17, 2016 Sale$11.9296311,4795,803Feb 18, 2016, 07:45 PM
Labrucherie Gil MSVP & General CounselFeb 10, 2016 Option Exercise$6.4611,66675,36216,917Feb 12, 2016, 05:20 PM
Labrucherie Gil MSVP & General CounselFeb 10, 2016 Sale$11.4911,666134,0425,251Feb 12, 2016, 05:20 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 10, 2016 Option Exercise$6.6515,00099,75018,999Feb 12, 2016, 05:19 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerFeb 10, 2016 Sale$11.4915,000172,3503,999Feb 12, 2016, 05:19 PM
ROBIN HOWARD WPresident & CEOFeb 10, 2016 Option Exercise$6.4666,666430,66276,666Feb 12, 2016, 05:18 PM
ROBIN HOWARD WPresident & CEOFeb 10, 2016 Sale$11.4966,666765,99210,000Feb 12, 2016, 05:18 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerJan 19, 2016 Option Exercise$6.6515,00099,75018,999Jan 21, 2016, 06:06 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerJan 19, 2016 Sale$14.1215,000211,8003,999Jan 21, 2016, 06:06 PM
ROBIN HOWARD WPresident & CEOJan 19, 2016 Option Exercise$6.4666,667430,66976,667Jan 21, 2016, 06:05 PM
ROBIN HOWARD WPresident & CEOJan 19, 2016 Sale$14.1266,667941,33810,000Jan 21, 2016, 06:05 PM
Lingnau LutzDirectorJan 20, 2016 Option Exercise$5.1515,00077,25031,450Jan 21, 2016, 06:04 PM
Lingnau LutzDirectorJan 20, 2016 Sale$14.5115,000217,65016,450Jan 21, 2016, 06:04 PM
Labrucherie Gil MSVP & General CounselJan 19, 2016 Option Exercise$6.4611,66775,36916,918Jan 21, 2016, 06:02 PM
Labrucherie Gil MSVP & General CounselJan 19, 2016 Sale$14.1211,667164,7385,251Jan 21, 2016, 06:02 PM
Labrucherie Gil MSVP & General CounselDec 03, 2015 Option Exercise$6.8545,001308,04050,252Dec 07, 2015, 05:36 PM
Labrucherie Gil MSVP & General CounselDec 03, 2015 Sale$15.8745,001714,1665,251Dec 07, 2015, 05:36 PM
ROBIN HOWARD WPresident & CEODec 03, 2015 Option Exercise$6.70125,001837,840135,001Dec 07, 2015, 05:33 PM
ROBIN HOWARD WPresident & CEODec 03, 2015 Sale$15.87125,0011,983,76610,000Dec 07, 2015, 05:33 PM
KUEBLER CHRISTOPHER ADirectorDec 04, 2015 Option Exercise$5.1515,00077,25035,000Dec 07, 2015, 05:31 PM
KUEBLER CHRISTOPHER ADirectorDec 04, 2015 Sale$15.8215,000237,30020,000Dec 07, 2015, 05:31 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerDec 03, 2015 Option Exercise$6.6515,00099,75018,999Dec 07, 2015, 05:29 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerDec 03, 2015 Sale$15.8715,000238,0503,999Dec 07, 2015, 05:29 PM
WANG SUSANDirectorNov 18, 2015 Option Exercise$7.5220,372153,16235,000Nov 20, 2015, 05:27 PM
WANG SUSANDirectorNov 20, 2015 Option Exercise$8.4549,500418,43060,000Nov 20, 2015, 05:27 PM
WANG SUSANDirectorNov 19, 2015 Option Exercise$5.1415,12877,75835,128Nov 20, 2015, 05:27 PM
WANG SUSANDirectorNov 18, 2015 Sale$15.0020,372305,58020,000Nov 20, 2015, 05:27 PM
WANG SUSANDirectorNov 20, 2015 Sale$15.0249,500743,49020,000Nov 20, 2015, 05:27 PM
WANG SUSANDirectorNov 19, 2015 Sale$15.0215,128227,22320,000Nov 20, 2015, 05:27 PM
ROBIN HOWARD WPresident & CEONov 11, 2015 Option Exercise$6.70125,000837,833135,000Nov 13, 2015, 05:41 PM
ROBIN HOWARD WPresident & CEONov 11, 2015 Sale$13.52125,0001,690,00010,000Nov 13, 2015, 05:41 PM
Labrucherie Gil MSVP & General CounselNov 11, 2015 Option Exercise$6.8545,000308,03349,751Nov 13, 2015, 05:35 PM
Labrucherie Gil MSVP & General CounselNov 11, 2015 Sale$13.5245,000608,4004,751Nov 13, 2015, 05:35 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerNov 11, 2015 Option Exercise$6.6515,00099,75018,499Nov 13, 2015, 04:12 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerNov 11, 2015 Sale$13.5215,000202,8003,499Nov 13, 2015, 04:12 PM
Lingnau LutzDirectorOct 28, 2015 Option Exercise$6.6512,50083,12528,950Oct 30, 2015, 04:17 PM
Lingnau LutzDirectorOct 28, 2015 Sale$12.0012,500150,00016,450Oct 30, 2015, 04:17 PM
GREER R SCOTTDirectorOct 15, 2015 Option Exercise$11.3432,500368,55083,333Oct 19, 2015, 05:01 PM
ROBIN HOWARD WPresident & CEOOct 06, 2015 Option Exercise$6.70125,000837,833135,000Oct 08, 2015, 07:12 PM
ROBIN HOWARD WPresident & CEOOct 06, 2015 Sale$10.99125,0001,373,75010,000Oct 08, 2015, 07:12 PM
Labrucherie Gil MSVP & General CounselOct 06, 2015 Option Exercise$6.8545,000308,03349,751Oct 08, 2015, 07:11 PM
Labrucherie Gil MSVP & General CounselOct 06, 2015 Sale$10.9945,000494,5504,751Oct 08, 2015, 07:11 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerOct 06, 2015 Option Exercise$6.6515,00099,75018,499Oct 08, 2015, 07:09 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerOct 06, 2015 Sale$10.9915,000164,8503,499Oct 08, 2015, 07:09 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerSep 23, 2015 Option Exercise$6.6510,00066,50013,499Sep 25, 2015, 05:25 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerSep 23, 2015 Sale$13.0410,000130,4003,499Sep 25, 2015, 05:25 PM
ROBIN HOWARD WPresident & CEOSep 23, 2015 Option Exercise$6.70124,999837,827134,999Sep 25, 2015, 05:24 PM
ROBIN HOWARD WPresident & CEOSep 23, 2015 Sale$13.04124,9991,629,98710,000Sep 25, 2015, 05:24 PM
Labrucherie Gil MSVP & General CounselSep 23, 2015 Option Exercise$6.8544,999308,02749,750Sep 25, 2015, 05:22 PM
Labrucherie Gil MSVP & General CounselSep 23, 2015 Sale$13.0444,999586,7874,751Sep 25, 2015, 05:22 PM
WHITFIELD ROY ADirectorSep 11, 2015 Option Exercise$8.8115,000132,15015,000Sep 15, 2015, 04:12 PM
Labrucherie Gil MSVP & General CounselAug 13, 2015 Option Exercise$6.9833,333232,66438,084Aug 17, 2015, 04:04 PM
Labrucherie Gil MSVP & General CounselAug 13, 2015 Sale$10.8933,333362,9964,751Aug 17, 2015, 04:04 PM
ROBIN HOWARD WPresident & CEOAug 13, 2015 Option Exercise$6.9858,333407,16468,333Aug 17, 2015, 04:03 PM
ROBIN HOWARD WPresident & CEOAug 13, 2015 Sale$10.8958,333635,24610,000Aug 17, 2015, 04:03 PM
Nicholson JohnSVP & Chief Financial OfficerAug 12, 2015 Option Exercise$6.4990,000584,000141,116Aug 13, 2015, 05:10 PM
Nicholson JohnSVP & Chief Financial OfficerAug 11, 2015 Option Exercise$8.26295,0002,437,100164,908Aug 13, 2015, 05:10 PM
Nicholson JohnSVP & Chief Financial OfficerAug 11, 2015 Sale$10.87249,9082,716,08910,000Aug 13, 2015, 05:10 PM
Nicholson JohnSVP & Chief Financial OfficerAug 12, 2015 Sale$10.4869,976733,32575,116Aug 13, 2015, 05:10 PM
Krivulka Joseph JDirectorJul 24, 2015 Option Exercise$8.8115,000132,15035,000Jul 28, 2015, 04:06 PM
ROBIN HOWARD WPresident & CEOJul 14, 2015 Option Exercise$6.9858,334407,17168,334Jul 16, 2015, 04:16 PM
ROBIN HOWARD WPresident & CEOJul 14, 2015 Sale$11.7858,334687,17510,000Jul 16, 2015, 04:16 PM
Labrucherie Gil MSVP & General CounselJul 14, 2015 Option Exercise$6.9833,334232,67137,585Jul 16, 2015, 04:14 PM
Labrucherie Gil MSVP & General CounselJul 14, 2015 Sale$11.7833,334392,6754,251Jul 16, 2015, 04:14 PM
WANG SUSANDirectorJun 29, 2015 Option Exercise$6.9830,000209,40035,000Jul 01, 2015, 04:09 PM
WANG SUSANDirectorJun 29, 2015 Sale$12.7030,000381,00020,000Jul 01, 2015, 04:09 PM
CHESS ROBERTDirectorJun 19, 2015 Option Exercise$8.8115,000132,150275,623Jun 23, 2015, 04:05 PM
CHESS ROBERTDirectorJun 19, 2015 Sale$11.8115,000177,150260,623Jun 23, 2015, 04:05 PM
Lingnau LutzDirectorJun 15, 2015 Option Exercise$6.6525,000166,25041,450Jun 17, 2015, 04:07 PM
Lingnau LutzDirectorJun 15, 2015 Sale$11.1525,000278,75016,450Jun 17, 2015, 04:07 PM
KUEBLER CHRISTOPHER ADirectorJan 13, 2015 Option Exercise$8.8115,000132,15035,000Jan 15, 2015, 05:54 PM
KUEBLER CHRISTOPHER ADirectorJan 13, 2015 Sale$16.0015,000240,00020,000Jan 15, 2015, 05:54 PM
CHESS ROBERTDirectorDec 29, 2014 Option Exercise$15.2429,500449,580290,123Dec 31, 2014, 05:37 PM
CHESS ROBERTDirectorDec 29, 2014 Sale$15.3429,500452,530260,623Dec 31, 2014, 05:37 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerDec 22, 2014 Option Exercise$11.385,00056,9007,999Dec 24, 2014, 04:09 PM
Thomsen Jillian B.SVP & Chief Accounting OfficerDec 22, 2014 Sale$15.565,00077,8002,999Dec 24, 2014, 04:09 PM
Labrucherie Gil MSVP & General CounselDec 01, 2014 Option Exercise$4.6530,000139,50034,251Dec 02, 2014, 07:23 PM
Labrucherie Gil MSVP & General CounselNov 28, 2014 Option Exercise$4.6590,000418,50094,251Dec 02, 2014, 07:23 PM
Labrucherie Gil MSVP & General CounselDec 01, 2014 Sale$17.0030,000510,0004,251Dec 02, 2014, 07:23 PM
Labrucherie Gil MSVP & General CounselNov 28, 2014 Sale$17.0290,0001,531,8004,251Dec 02, 2014, 07:23 PM
ROBIN HOWARD WPresident & CEODec 01, 2014 Option Exercise$6.98209,0561,459,211219,056Dec 02, 2014, 07:22 PM
ROBIN HOWARD WPresident & CEONov 28, 2014 Option Exercise$6.98140,944983,789150,944Dec 02, 2014, 07:22 PM
ROBIN HOWARD WPresident & CEONov 28, 2014 Sale$17.02140,9442,398,86710,000Dec 02, 2014, 07:22 PM
ROBIN HOWARD WPresident & CEODec 01, 2014 Sale$17.00209,0563,553,95210,000Dec 02, 2014, 07:22 PM
Labrucherie Gil MSVP & General CounselNov 24, 2014 Option Exercise$13.0210,500136,71014,251Nov 26, 2014, 05:47 PM
Labrucherie Gil MSVP & General CounselNov 24, 2014 Sale$15.0410,500157,9203,751Nov 26, 2014, 05:47 PM
ROBIN HOWARD WPresident & CEONov 25, 2014 Option Exercise$14.52467,2006,783,744477,200Nov 26, 2014, 05:41 PM
ROBIN HOWARD WPresident & CEONov 24, 2014 Option Exercise$14.52132,8001,928,256142,800Nov 26, 2014, 05:41 PM
ROBIN HOWARD WPresident & CEONov 24, 2014 Sale$15.02132,8001,994,65610,000Nov 26, 2014, 05:41 PM
ROBIN HOWARD WPresident & CEONov 25, 2014 Sale$15.31467,2007,152,83210,000Nov 26, 2014, 05:41 PM
Lingnau LutzDirectorNov 24, 2014 Option Exercise$8.8115,000132,15031,450Nov 26, 2014, 05:39 PM
Lingnau LutzDirectorNov 24, 2014 Sale$15.0215,000225,30016,450Nov 26, 2014, 05:39 PM
Labrucherie Gil MSVP & General CounselNov 03, 2014 Option Exercise$11.389,900112,66213,651Nov 04, 2014, 01:41 PM
Labrucherie Gil MSVP & General CounselNov 03, 2014 Sale$13.789,900136,4223,751Nov 04, 2014, 01:41 PM
KUEBLER CHRISTOPHER ADirectorAug 05, 2013 Option Exercise$11.4112,500142,62532,500Aug 08, 2013, 05:14 PM
KUEBLER CHRISTOPHER ADirectorAug 05, 2013 Sale$12.4112,500155,12520,000Aug 08, 2013, 05:14 PM
WHITFIELD ROY ADirectorAug 05, 2013 Option Exercise$11.4112,500142,62532,500Aug 07, 2013, 04:30 PM
WHITFIELD ROY ADirectorAug 05, 2013 Sale$12.4112,500155,12520,000Aug 07, 2013, 04:30 PM
KUEBLER CHRISTOPHER ADirectorSep 27, 2012 Option Exercise$8.6612,500108,25032,500Oct 01, 2012, 04:02 PM
KUEBLER CHRISTOPHER ADirectorSep 27, 2012 Sale$10.6612,500133,25020,000Oct 01, 2012, 04:02 PM
WINGER DENNIS LDirectorSep 14, 2012 Buy$9.185,00045,9085,000Sep 18, 2012, 02:34 PM
CHESS ROBERTDirectorJul 13, 2012 Option Exercise$6.1224,001146,886284,624Jul 17, 2012, 04:10 PM
CHESS ROBERTDirectorJul 13, 2012 Sale$8.5024,001204,009260,623Jul 17, 2012, 04:10 PM
CHESS ROBERTDirectorMar 08, 2011 Sale$9.004,50040,500255,709Mar 09, 2011, 12:14 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Zalevsky JonathanChief R&D Officer02/20/20246,130
Wilson Mark AndrewChief Legal Officer02/20/20245,172
ROBIN HOWARD WPresident & CEO02/20/202413,622
Zalevsky JonathanChief R&D Officer11/17/20234,727
Wilson Mark AndrewChief Legal Officer11/17/20233,518
ROBIN HOWARD WPresident & CEO11/17/20239,740
Curet MyriamDirector09/18/20233,008
CHESS ROBERTDirector09/22/20226,834
Ajer Jeffrey RobertDirector09/18/20233,008
Zalevsky JonathanChief R&D Officer08/16/20237,568
Wilson Mark AndrewChief Legal Officer08/16/20235,632
ROBIN HOWARD WPresident & CEO08/16/202315,598
WHITFIELD ROY ADirector06/14/202317,100
Zalevsky JonathanChief R&D Officer05/16/20237,050
Wilson Mark AndrewChief Legal Officer05/16/20235,431
ROBIN HOWARD WPresident & CEO05/16/202314,660
Zalevsky JonathanChief R&D Officer02/16/202331,452
Wilson Mark AndrewChief Legal Officer02/16/202324,825
Thomsen Jillian B.Chief Financial Officer02/16/202330,801
ROBIN HOWARD WPresident & CEO02/16/202358,905
Zalevsky JonathanChief R&D Officer11/16/202248,052
Wilson Mark AndrewChief Legal Officer11/16/202231,023
Thomsen Jillian B.Chief Financial Officer11/16/202239,609
ROBIN HOWARD WPresident & CEO11/16/2022135,710
Curet MyriamDirector09/23/202213,266
Ajer Jeffrey RobertDirector09/23/202213,266
CHESS ROBERTDirector09/22/202216,269
EASTHAM KARINDirector09/13/202276,774
Zalevsky JonathanChief R&D Officer08/18/2022342,779
Zalevsky JonathanChief R&D Officer08/16/202250,266
Wilson Mark AndrewSVP & General Counsel08/16/202215,180
Thomsen Jillian B.SVP & Chief Accounting Officer08/16/20229,549
ROBIN HOWARD WPresident & CEO08/16/202265,493
Zalevsky JonathanChief R&D Officer05/16/202285,608
Wilson Mark AndrewSVP & General Counsel05/16/202212,387
Thomsen Jillian B.SVP & Chief Accounting Officer05/16/202223,072
ROBIN HOWARD WPresident & CEO05/16/2022144,290
NORTHCOTT JOHNSVP & Chief Commercial Officer05/16/202218,138
Labrucherie Gil MSVP, COO & CFO05/16/202268,920
Zalevsky JonathanChief R&D Officer02/16/2022119,486
Wilson Mark AndrewSVP & General Counsel02/16/202240,088
Thomsen Jillian B.SVP & Chief Accounting Officer02/16/202225,875
ROBIN HOWARD WPresident & CEO02/16/2022136,656
NORTHCOTT JOHNSVP & Chief Commercial Officer02/16/202253,129
Labrucherie Gil MSVP, COO & CFO02/16/202282,990
Labrucherie Gil MSVP, COO & CFO11/18/202138,070
Labrucherie Gil MSVP, COO & CFO11/16/2021278,321
Zalevsky JonathanChief R&D Officer11/16/2021274,636
Wilson Mark AndrewSVP & General Counsel11/16/202186,382
Thomsen Jillian B.SVP & Chief Accounting Officer11/16/202188,712
ROBIN HOWARD WPresident & CEO11/16/2021562,893
NORTHCOTT JOHNSVP & Chief Commercial Officer11/16/202179,763
GREER R SCOTTDirector11/09/2021160,000
Curet MyriamDirector09/22/202165,164
CHESS ROBERTDirector09/22/202182,524
Ajer Jeffrey RobertDirector09/22/202165,164
WHITFIELD ROY ADirector09/16/2021552,000
CHESS ROBERTDirector09/09/2021141,850
CHESS ROBERTDirector09/08/2021110,400
CHESS ROBERTDirector09/09/2021164,670
CHESS ROBERTDirector09/08/2021128,000
GREER R SCOTTDirector08/31/2021571,500
Zalevsky JonathanChief R&D Officer08/16/2021105,965
Wilson Mark AndrewSVP & General Counsel08/16/202126,415
ROBIN HOWARD WPresident & CEO08/16/2021159,252
Thomsen Jillian B.SVP & Chief Accounting Officer08/16/2021184,478
NORTHCOTT JOHNSVP & Chief Commercial Officer08/16/202185,635
Labrucherie Gil MSVP, COO & CFO08/17/202140,680
Labrucherie Gil MSVP, COO & CFO08/16/2021108,801
CHESS ROBERTDirector07/22/20211,256
CHESS ROBERTDirector07/21/202148,631
CHESS ROBERTDirector07/20/202129,063
CHESS ROBERTDirector07/22/20211,529
CHESS ROBERTDirector07/21/202159,238
CHESS ROBERTDirector07/20/202135,381
Labrucherie Gil MSVP, COO & CFO05/17/2021144,533
CHESS ROBERTDirector05/12/2021110,400
CHESS ROBERTDirector05/12/2021154,720
CHESS ROBERTDirector04/14/2021110,400
CHESS ROBERTDirector04/14/2021151,840
Zalevsky JonathanChief R&D Officer02/16/2021540,034
Wilson Mark AndrewSVP & General Counsel02/16/202148,610
Thomsen Jillian B.SVP & Chief Accounting Officer02/16/2021261,841
ROBIN HOWARD WPresident & CEO02/16/2021257,143
NORTHCOTT JOHNSVP & Chief Commercial Officer02/16/2021343,558
Labrucherie Gil MSVP, COO & CFO02/16/2021178,445
Wilson Mark AndrewSVP & General Counsel02/03/202147,027
Wilson Mark AndrewSVP & General Counsel02/03/2021103,941
ROBIN HOWARD WPresident & CEO02/04/20211,320,000
ROBIN HOWARD WPresident & CEO02/03/20211,320,000
ROBIN HOWARD WPresident & CEO02/02/20211,320,000
ROBIN HOWARD WPresident & CEO02/04/20213,042,906
ROBIN HOWARD WPresident & CEO02/03/20212,958,000
ROBIN HOWARD WPresident & CEO02/02/20212,966,025
Labrucherie Gil MSVP, COO & CFO02/04/2021440,000
Labrucherie Gil MSVP, COO & CFO02/03/2021440,000
Labrucherie Gil MSVP, COO & CFO02/02/2021440,000
Labrucherie Gil MSVP, COO & CFO02/04/2021990,500
Labrucherie Gil MSVP, COO & CFO02/03/2021980,500
Labrucherie Gil MSVP, COO & CFO02/02/20211,008,629
Thomsen Jillian B.SVP & Chief Accounting Officer01/28/2021660,000
Thomsen Jillian B.SVP & Chief Accounting Officer01/28/20211,396,500
GREER R SCOTTDirector01/05/2021552,000
Myriam CuretDirector12/15/202027,799
Zalevsky JonathanChief R&D Officer11/23/2020268,632
Zalevsky JonathanChief R&D Officer11/16/2020501,433
Wilson Mark AndrewSVP & General Counsel11/16/202026,055
Thomsen Jillian B.SVP & Chief Accounting Officer11/16/2020202,754
ROBIN HOWARD WPresident & CEO11/16/2020202,737
Labrucherie Gil MSVP, COO & CFO11/16/2020140,113
Ajer Jeffrey RobertDirector09/28/202056,063
CHESS ROBERTDirector09/25/202097,625
Labrucherie Gil MSVP, COO & CFO09/17/202039,920
Ajer Jeffrey RobertDirector09/21/202044,415
CHESS ROBERTDirector09/08/202073,920
CHESS ROBERTDirector09/08/2020148,240
WHITFIELD ROY ADirector09/04/2020277,200
Zalevsky JonathanChief R&D Officer08/17/2020515,354
Wilson Mark AndrewSVP & General Counsel08/17/202030,075
Thomsen Jillian B.SVP & Chief Accounting Officer08/17/202026,889
ROBIN HOWARD WPresident & CEO08/17/2020233,778
Labrucherie Gil MSVP, COO & CFO08/18/202039,360
Labrucherie Gil MSVP, COO & CFO08/17/2020122,839
GREER R SCOTTDirector07/09/2020369,600
GREER R SCOTTDirector07/09/2020375,225
CHESS ROBERTDirector07/08/202073,920
CHESS ROBERTDirector07/08/2020196,640
Zalevsky JonathanChief R&D Officer05/18/2020102,601
Wilson Mark AndrewSVP & General Counsel05/18/202034,418
Thomsen Jillian B.SVP & Chief Accounting Officer05/18/202030,771
ROBIN HOWARD WPresident & CEO05/18/2020201,870
Labrucherie Gil MSVP, COO & CFO05/18/2020128,915
Labrucherie Gil MSVP, COO & CFO05/19/202045,240
CHESS ROBERTDirector04/15/202073,920
CHESS ROBERTDirector04/15/2020147,010
CHESS ROBERTDirector03/11/202073,920
CHESS ROBERTDirector03/11/2020134,316
Zalevsky JonathanChief R&D Officer02/18/2020106,699
Thomsen Jillian B.SVP & Chief Accounting Officer02/18/202031,156
ROBIN HOWARD WPresident & CEO02/18/2020188,813
Labrucherie Gil MSVP, COO & CFO02/18/2020132,714
CHESS ROBERTDirector02/12/202073,920
CHESS ROBERTDirector02/12/2020188,000
Thomsen Jillian B.SVP & Chief Accounting Officer02/06/2020270,375
Thomsen Jillian B.SVP & Chief Accounting Officer02/06/2020854,250
WHITFIELD ROY ADirector12/18/201992,400
Zalevsky JonathanChief R&D Officer11/18/201971,161
Thomsen Jillian B.SVP & Chief Accounting Officer11/18/201948,753
ROBIN HOWARD WPresident & CEO11/18/2019243,601
Labrucherie Gil MSVP, COO & CFO11/18/2019159,268
Labrucherie Gil MSVP, COO & CFO11/13/2019180,250
Labrucherie Gil MSVP, COO & CFO11/13/2019494,750
ROBIN HOWARD WPresident & CEO10/15/2019240,331
ROBIN HOWARD WPresident & CEO10/17/2019240,331
ROBIN HOWARD WPresident & CEO10/16/2019240,338
ROBIN HOWARD WPresident & CEO10/17/2019589,327
ROBIN HOWARD WPresident & CEO10/16/2019582,678
ROBIN HOWARD WPresident & CEO10/15/2019565,085
Labrucherie Gil MSVP, COO & CFO10/15/2019180,250
Labrucherie Gil MSVP, COO & CFO10/15/2019395,750
Lingnau LutzDirector09/27/201953,520
Ajer Jeffrey RobertDirector09/30/201942,892
CHESS ROBERTDirector09/27/201971,960
Ajer Jeffrey RobertDirector09/20/201945,540
Labrucherie Gil MSVP & Chief Financial Officer09/16/2019180,250
Labrucherie Gil MSVP & Chief Financial Officer09/16/2019513,000
Doberstein Stephen KSVP & Chief Scientific Officer09/05/2019259,200
Labrucherie Gil MSVP & Chief Financial Officer08/26/2019489,300
ROBIN HOWARD WPresident & CEO08/23/2019489,300
Thomsen Jillian B.SVP & Chief Accounting Officer08/16/201932,833
ROBIN HOWARD WPresident & CEO08/16/2019227,801
Nicholson JohnSVP & Chief Operating Officer08/16/201969,315
Labrucherie Gil MSVP & Chief Financial Officer08/16/201991,893
Doberstein Stephen KSVP & Chief Scientific Officer08/16/201958,897
Labrucherie Gil MSVP & Chief Financial Officer08/14/2019180,250
Labrucherie Gil MSVP & Chief Financial Officer08/14/2019444,750
ROBIN HOWARD WPresident & CEO07/24/2019240,338
ROBIN HOWARD WPresident & CEO07/23/2019240,331
ROBIN HOWARD WPresident & CEO07/25/2019240,331
ROBIN HOWARD WPresident & CEO07/24/20191,070,355
ROBIN HOWARD WPresident & CEO07/23/20191,069,989
ROBIN HOWARD WPresident & CEO07/25/2019988,323
Labrucherie Gil MSVP & Chief Financial Officer07/10/2019180,250
Labrucherie Gil MSVP & Chief Financial Officer07/10/2019864,250
Lingnau LutzDirector07/08/201992,400
Lingnau LutzDirector07/08/2019346,300
Labrucherie Gil MSVP & Chief Financial Officer06/17/2019180,250
Labrucherie Gil MSVP & Chief Financial Officer06/17/2019842,750
ROBIN HOWARD WPresident & CEO05/22/2019240,338
ROBIN HOWARD WPresident & CEO05/21/2019240,331
ROBIN HOWARD WPresident & CEO05/23/2019240,331
ROBIN HOWARD WPresident & CEO05/21/20191,097,656
ROBIN HOWARD WPresident & CEO05/23/20191,089,656
ROBIN HOWARD WPresident & CEO05/22/20191,112,689
Thomsen Jillian B.SVP & Chief Accounting Officer05/16/201960,481
ROBIN HOWARD WPresident & CEO05/16/2019419,825
Nicholson JohnSVP & Chief Operating Officer05/16/2019127,895
Labrucherie Gil MSVP & Chief Financial Officer05/16/2019118,171
Hora ManinderSVP Pharma Dev & Mfg Ops05/16/201976,825
Doberstein Stephen KSVP & Chief Scientific Officer05/16/2019108,572
GREER R SCOTTDirector03/08/201951,400
Thomsen Jillian B.SVP & Chief Accounting Officer02/19/201976,641
ROBIN HOWARD WPresident & CEO02/20/2019240,338
ROBIN HOWARD WPresident & CEO02/19/2019240,331
ROBIN HOWARD WPresident & CEO02/21/2019240,331
ROBIN HOWARD WPresident & CEO02/20/20191,440,029
ROBIN HOWARD WPresident & CEO02/19/20191,787,161
ROBIN HOWARD WPresident & CEO02/21/20191,366,986
Nicholson JohnSVP & Chief Operating Officer02/19/2019162,015
Labrucherie Gil MSVP & Chief Financial Officer02/19/2019152,265
Hora ManinderSVP Pharma Dev & Mfg Ops02/19/2019101,143
Doberstein Stephen KSVP & Chief Scientific Officer02/19/2019140,311
Thomsen Jillian B.SVP & Chief Accounting Officer02/04/2019172,312
Thomsen Jillian B.SVP & Chief Accounting Officer02/04/2019679,577
Nicholson JohnSVP & Chief Operating Officer01/28/2019673,470
Nicholson JohnSVP & Chief Operating Officer01/28/20192,697,660
Thomsen Jillian B.SVP & Chief Accounting Officer11/16/2018153,612
ROBIN HOWARD WPresident & CEO11/16/2018586,220
Nicholson JohnSVP & Chief Operating Officer11/16/2018228,812
Labrucherie Gil MSVP & Chief Financial Officer11/16/2018249,199
Hora ManinderSVP Pharma Dev & Mfg Ops11/16/2018179,546
Doberstein Stephen KSVP & Chief Scientific Officer11/16/2018173,043
Lingnau LutzDirector09/20/2018512,820
CHESS ROBERTDirector09/19/2018255,645
Ajer Jeffrey RobertDirector09/20/2018383,130
GREER R SCOTTDirector09/04/201851,400
GREER R SCOTTDirector09/04/2018673,900
WINGER DENNIS LDirector08/17/2018213,900
WINGER DENNIS LDirector08/21/2018213,900
WINGER DENNIS LDirector08/21/2018904,500
WINGER DENNIS LDirector08/17/2018894,300
Thomsen Jillian B.SVP & Chief Accounting Officer08/16/2018285,167
Nicholson JohnSVP & Chief Operating Officer08/16/2018475,201
Labrucherie Gil MSVP & Chief Financial Officer08/16/2018479,289
Hora ManinderSVP Pharma Dev & Mfg Ops08/16/2018347,246
ROBIN HOWARD WPresident & CEO08/14/2018427,600
ROBIN HOWARD WPresident & CEO08/16/20181,190,718
ROBIN HOWARD WPresident & CEO08/14/20182,403,200
Doberstein Stephen KSVP & Chief Scientific Officer08/16/2018391,338
WINGER DENNIS LDirector08/14/20181,030,069
WINGER DENNIS LDirector08/13/20181,045,310
ROBIN HOWARD WPresident & CEO06/26/2018463,230
ROBIN HOWARD WPresident & CEO06/25/2018463,240
ROBIN HOWARD WPresident & CEO06/27/2018463,230
ROBIN HOWARD WPresident & CEO06/26/20182,138,917
ROBIN HOWARD WPresident & CEO06/25/20182,245,568
ROBIN HOWARD WPresident & CEO06/27/20182,053,551
WHITFIELD ROY ADirector06/06/2018201,860
WHITFIELD ROY ADirector06/05/201888,352
CHESS ROBERTDirector06/05/2018142,600
CHESS ROBERTDirector06/05/2018551,600
GREER R SCOTTDirector06/06/201844,204
GREER R SCOTTDirector06/04/20187,196
GREER R SCOTTDirector06/06/2018516,000
GREER R SCOTTDirector06/04/201886,786
Thomsen Jillian B.SVP & Chief Accounting Officer05/16/2018298,203
ROBIN HOWARD WPresident & CEO05/16/20181,066,641
Nicholson JohnSVP & Chief Operating Officer05/16/2018410,029
Labrucherie Gil MSVP & Chief Financial Officer05/16/2018412,030
Hora ManinderSVP Pharma Dev & Mfg Ops05/16/2018338,563
Doberstein Stephen KSVP & Chief Scientific Officer05/16/2018286,445
CHESS ROBERTDirector05/03/2018219,700
CHESS ROBERTDirector05/03/20182,070,050
Labrucherie Gil MSVP & Chief Financial Officer05/03/2018320,700
Labrucherie Gil MSVP & Chief Financial Officer05/02/2018320,700
Labrucherie Gil MSVP & Chief Financial Officer05/01/2018320,700
Labrucherie Gil MSVP & Chief Financial Officer05/03/20182,485,800
Labrucherie Gil MSVP & Chief Financial Officer05/02/20182,568,900
Labrucherie Gil MSVP & Chief Financial Officer05/01/20182,509,500
ROBIN HOWARD WPresident & CEO05/03/2018463,230
ROBIN HOWARD WPresident & CEO05/02/2018463,230
ROBIN HOWARD WPresident & CEO05/01/2018463,240
ROBIN HOWARD WPresident & CEO05/03/20183,590,572
ROBIN HOWARD WPresident & CEO05/02/20183,710,605
ROBIN HOWARD WPresident & CEO05/01/20183,624,889
WHITFIELD ROY ADirector04/17/2018427,800
Thomsen Jillian B.SVP & Chief Accounting Officer04/16/2018148,388
Thomsen Jillian B.SVP & Chief Accounting Officer04/16/20181,408,366
Hora ManinderSVP Pharma Dev & Mfg Ops04/10/20183,619
Hora ManinderSVP Pharma Dev & Mfg Ops04/10/201853,046
Lingnau LutzDirector04/05/2018277,200
Lingnau LutzDirector04/05/20183,052,200
Hora ManinderSVP Pharma Dev & Mfg Ops04/09/201868,481
Hora ManinderSVP Pharma Dev & Mfg Ops04/05/2018144,200
Hora ManinderSVP Pharma Dev & Mfg Ops04/09/2018997,765
Hora ManinderSVP Pharma Dev & Mfg Ops04/05/20182,035,000
GREER R SCOTTDirector04/06/2018427,800
GREER R SCOTTDirector04/06/20182,766,600
Doberstein Stephen KSVP & Chief Scientific Officer04/09/2018356,895
Doberstein Stephen KSVP & Chief Scientific Officer04/06/20181,005,505
Doberstein Stephen KSVP & Chief Scientific Officer04/09/20184,758,435
Doberstein Stephen KSVP & Chief Scientific Officer04/06/201810,131,745
CHESS ROBERTDirector04/06/2018219,700
CHESS ROBERTDirector04/06/20182,303,600
KUEBLER CHRISTOPHER ADirector03/07/2018233,236
KUEBLER CHRISTOPHER ADirector03/06/201813,364
KUEBLER CHRISTOPHER ADirector03/06/2018260,780
KUEBLER CHRISTOPHER ADirector03/07/20183,643,134
Nicholson JohnSVP & Chief Operating Officer03/07/201810,059,464
Nicholson JohnSVP & Chief Operating Officer03/06/201811,794,800
Thomsen Jillian B.SVP & Chief Accounting Officer02/16/2018211,082
ROBIN HOWARD WPresident & CEO02/16/20181,060,637
Nicholson JohnSVP & Chief Operating Officer02/16/2018404,664
Labrucherie Gil MSVP & Chief Financial Officer02/16/2018288,382
Hora ManinderSVP Pharma Dev & Mfg Ops02/16/2018238,453
Doberstein Stephen KSVP & Chief Scientific Officer02/16/2018201,212
Nicholson JohnSVP & Chief Operating Officer01/31/20181,360,800
ROBIN HOWARD WPresident & CEO01/22/2018944,996
ROBIN HOWARD WPresident & CEO01/22/20186,318,308
WINGER DENNIS LDirector01/04/2018403,988
KUEBLER CHRISTOPHER ADirector01/02/2018427,800
KUEBLER CHRISTOPHER ADirector01/02/20181,759,800
ROBIN HOWARD WPresident & CEO12/13/2017944,996
ROBIN HOWARD WPresident & CEO12/13/20174,640,815
Thomsen Jillian B.SVP & Chief Accounting Officer11/16/2017233,932
ROBIN HOWARD WPresident & CEO11/16/2017799,192
Nicholson JohnSVP & Chief Operating Officer11/16/2017292,803
Labrucherie Gil MSVP & Chief Financial Officer11/16/2017296,253
Hora ManinderSVP Pharma Dev & Mfg Ops11/16/2017247,555
Gergel Ivan P.SVP & Chief Medical Officer11/16/2017222,123
Doberstein Stephen KSVP & Chief Scientific Officer11/16/2017211,508
Nicholson JohnSVP & Chief Operating Officer11/13/2017231,000
Nicholson JohnSVP & Chief Operating Officer11/13/2017601,080
Hora ManinderSVP Pharma Dev & Mfg Ops11/07/2017626,260
Hora ManinderSVP Pharma Dev & Mfg Ops11/06/201754,701
Hora ManinderSVP Pharma Dev & Mfg Ops11/06/2017128,283
Doberstein Stephen KSVP & Chief Scientific Officer11/06/2017199,310
Doberstein Stephen KSVP & Chief Scientific Officer11/08/20172,859,000
Doberstein Stephen KSVP & Chief Scientific Officer11/07/2017718,648
Doberstein Stephen KSVP & Chief Scientific Officer11/06/2017522,432
Doberstein Stephen KSVP & Chief Scientific Officer11/08/20179,027,000
Doberstein Stephen KSVP & Chief Scientific Officer11/07/20171,944,044
ROBIN HOWARD WPresident & CEO11/01/2017945,008
ROBIN HOWARD WPresident & CEO11/01/20171,964,182
ROBIN HOWARD WPresident & CEO10/09/2017944,996
ROBIN HOWARD WPresident & CEO10/09/20172,016,659
Hora ManinderSVP Pharma Dev & Mfg Ops10/05/201781,062
Hora ManinderSVP Pharma Dev & Mfg Ops10/05/2017189,575
Doberstein Stephen KSVP & Chief Scientific Officer10/05/2017416,242
Doberstein Stephen KSVP & Chief Scientific Officer10/05/20171,090,615
Labrucherie Gil MSVP & Chief Financial Officer10/02/20171,360,800
Labrucherie Gil MSVP & Chief Financial Officer10/02/20172,934,000
Gergel Ivan P.SVP & Chief Medical Officer10/02/2017626,012
Gergel Ivan P.SVP & Chief Medical Officer09/29/2017477,988
Gergel Ivan P.SVP & Chief Medical Officer10/02/20171,372,804
Gergel Ivan P.SVP & Chief Medical Officer09/29/20171,040,836
Lingnau LutzDirector09/22/2017109,850
KUEBLER CHRISTOPHER ADirector09/22/201787,440
CHESS ROBERTDirector09/21/2017139,008
ROBIN HOWARD WPresident & CEO09/06/2017944,996
ROBIN HOWARD WPresident & CEO09/06/20171,794,993
Thomsen Jillian B.SVP & Chief Accounting Officer08/16/201751,159
ROBIN HOWARD WPresident & CEO08/16/2017945,008
ROBIN HOWARD WPresident & CEO08/16/20171,766,081
Nicholson JohnSVP & Chief Operating Officer08/16/201761,380
Labrucherie Gil MSVP & Chief Financial Officer08/16/201761,380
Hora ManinderSVP Pharma Dev & Mfg Ops08/16/201757,110
Gergel Ivan P.SVP & Chief Medical Officer08/16/201738,582
Doberstein Stephen KSVP & Chief Scientific Officer08/16/201732,863
WHITFIELD ROY ADirector08/10/2017628,250
Gergel Ivan P.SVP & Chief Medical Officer07/18/2017606,317
Gergel Ivan P.SVP & Chief Medical Officer07/18/20171,158,812
Lingnau LutzDirector07/14/2017427,800
Lingnau LutzDirector07/14/2017622,800
Gergel Ivan P.SVP & Chief Medical Officer07/11/201792,615
Gergel Ivan P.SVP & Chief Medical Officer07/12/2017405,069
Gergel Ivan P.SVP & Chief Medical Officer07/11/2017176,505
Gergel Ivan P.SVP & Chief Medical Officer07/12/2017773,813
Krivulka Joseph JDirector06/26/2017125,550
Nicholson JohnSVP & Chief Operating Officer06/07/2017951,000
Nicholson JohnSVP & Chief Operating Officer06/07/20171,956,708
Thomsen Jillian B.SVP & Chief Accounting Officer05/16/201751,827
ROBIN HOWARD WPresident & CEO05/16/2017163,985
Nicholson JohnSVP & Chief Operating Officer05/16/201761,504
Labrucherie Gil MSVP & Chief Financial Officer05/16/201762,149
Hora ManinderSVP Pharma Dev & Mfg Ops05/16/201757,848
Gergel Ivan P.SVP & Chief Medical Officer05/16/201728,347
Doberstein Stephen KSVP & Chief Scientific Officer05/16/201733,255
CHESS ROBERTDirector05/15/201741,850
CHESS ROBERTDirector05/15/201798,950
CHESS ROBERTDirector04/17/201741,850
CHESS ROBERTDirector04/17/201793,600
Lingnau LutzDirector04/07/2017140,350
Doberstein Stephen KSVP & Chief Scientific Officer04/05/2017953,000
Doberstein Stephen KSVP & Chief Scientific Officer04/05/20172,170,000
Hora ManinderSVP Pharma Dev & Mfg Ops04/05/20172,466,000
Hora ManinderSVP Pharma Dev & Mfg Ops04/05/20173,906,000
KUEBLER CHRISTOPHER ADirector04/05/2017125,550
KUEBLER CHRISTOPHER ADirector04/05/2017328,200
Thomsen Jillian B.SVP & Chief Accounting Officer03/20/20171,120,875
Thomsen Jillian B.SVP & Chief Accounting Officer03/20/20172,215,125
WHITFIELD ROY ADirector03/15/2017117,180
CHESS ROBERTDirector03/14/201741,850
CHESS ROBERTDirector03/14/201777,050
Labrucherie Gil MSVP & Chief Financial Officer03/03/2017278,512
Labrucherie Gil MSVP & Chief Financial Officer03/02/20171,061,988
Labrucherie Gil MSVP & Chief Financial Officer03/03/2017494,234
Labrucherie Gil MSVP & Chief Financial Officer03/02/20172,537,716
Lingnau LutzDirector02/21/2017154,200
Lingnau LutzDirector02/21/2017392,400
Thomsen Jillian B.SVP & Chief Accounting Officer02/16/201725,820
ROBIN HOWARD WPresident & CEO02/16/2017113,477
Nicholson JohnSVP & Chief Operating Officer02/16/201742,534
Labrucherie Gil MSVP & Chief Financial Officer02/16/201730,997
Hora ManinderSVP Pharma Dev & Mfg Ops02/16/201728,842
Gergel Ivan P.SVP & Chief Medical Officer02/16/201719,145
Doberstein Stephen KSVP & Chief Scientific Officer02/16/201716,570
Nicholson JohnSVP & Chief Operating Officer02/10/2017209,250
ROBIN HOWARD WPresident & CEO02/08/2017406,875
ROBIN HOWARD WPresident & CEO02/08/20171,141,000
Nicholson JohnSVP & Chief Operating Officer02/02/2017309,202
Nicholson JohnSVP & Chief Operating Officer02/03/201739,548
Nicholson JohnSVP & Chief Operating Officer02/02/2017823,208
Nicholson JohnSVP & Chief Operating Officer02/03/2017106,142
ROBIN HOWARD WPresident & CEO01/17/2017406,875
ROBIN HOWARD WPresident & CEO01/17/20171,080,625
ROBIN HOWARD WPresident & CEO12/07/2016406,875
ROBIN HOWARD WPresident & CEO12/07/20161,071,000
Thomsen Jillian B.SVP & Chief Accounting Officer11/16/201627,725
ROBIN HOWARD WPresident & CEO11/17/2016406,875
ROBIN HOWARD WPresident & CEO11/17/20161,213,625
ROBIN HOWARD WPresident & CEO11/16/201683,174
Nicholson JohnSVP & Chief Operating Officer11/16/201623,090
Labrucherie Gil MSVP & Chief Financial Officer11/16/201623,090
Hora ManinderSVP Pharma Dev & Mfg Ops11/16/201623,090
Gergel Ivan P.SVP & Chief Medical Officer11/16/201611,838
Doberstein Stephen KSVP & Chief Scientific Officer11/16/20169,353
GREER R SCOTTDirector10/24/2016202,500
ROBIN HOWARD WPresident & CEO10/04/2016406,875
ROBIN HOWARD WPresident & CEO10/04/20161,492,750
WHITFIELD ROY ADirector09/23/2016239,820
Lingnau LutzDirector09/15/2016171,540
KUEBLER CHRISTOPHER ADirector09/16/2016143,475
CHESS ROBERTDirector09/15/2016230,520
ROBIN HOWARD WPresident & CEO09/01/2016406,875
ROBIN HOWARD WPresident & CEO09/01/20161,560,125
Nicholson JohnSVP & Chief Operating Officer08/16/201658,247
Thomsen Jillian B.SVP & Chief Accounting Officer08/16/201669,731
ROBIN HOWARD WPresident & CEO08/16/2016207,507
Labrucherie Gil MSVP & Chief Financial Officer08/16/201658,036
Hora ManinderSVP Pharma Dev & Mfg Ops08/16/201658,036
Gergel Ivan P.SVP & Chief Medical Officer08/16/201629,589
Doberstein Stephen KSVP & Chief Scientific Officer08/16/201623,460
CHESS ROBERTDirector08/01/201625,750
CHESS ROBERTDirector08/01/201686,300
Thomsen Jillian B.SVP & Chief Accounting Officer07/11/2016465,000
Thomsen Jillian B.SVP & Chief Accounting Officer07/11/20161,509,000
CHESS ROBERTDirector07/01/201625,750
CHESS ROBERTDirector07/01/201670,500
CHESS ROBERTDirector06/01/201625,750
CHESS ROBERTDirector06/01/201677,500
Nicholson JohnSVP & Chief Financial Officer05/16/20160
Nicholson JohnSVP & Chief Financial Officer05/17/201611,624
ROBIN HOWARD WPresident & CEO05/16/20161
ROBIN HOWARD WPresident & CEO05/17/201629,469
Doberstein Stephen KSVP & Chief Scientific Officer05/16/20160
Doberstein Stephen KSVP & Chief Scientific Officer05/17/20164,604
Gergel Ivan P.SVP & Chief Medical Officer05/16/20160
Gergel Ivan P.SVP & Chief Medical Officer05/17/20165,867
Hora ManinderSVP Pharma Dev & Mfg Ops05/16/20160
Hora ManinderSVP Pharma Dev & Mfg Ops05/17/201611,339
Labrucherie Gil MSVP & General Counsel05/16/20160
Labrucherie Gil MSVP & General Counsel05/17/201611,353
Thomsen Jillian B.SVP & Chief Accounting Officer05/16/20160
Thomsen Jillian B.SVP & Chief Accounting Officer05/17/20169,832
Lingnau LutzDirector04/25/2016125,550
Lingnau LutzDirector04/25/2016244,050
Thomsen Jillian B.SVP & Chief Accounting Officer03/09/201699,750
Thomsen Jillian B.SVP & Chief Accounting Officer03/09/2016176,850
Gergel Ivan P.SVP & Chief Medical Officer02/16/20160
Gergel Ivan P.SVP & Chief Medical Officer02/17/20166,628
Nicholson JohnSVP & Chief Financial Officer02/16/20160
Nicholson JohnSVP & Chief Financial Officer02/17/201611,479
ROBIN HOWARD WPresident & CEO02/16/20161
ROBIN HOWARD WPresident & CEO02/17/201625,592
Doberstein Stephen KSVP & Chief Scientific Officer02/16/20160
Doberstein Stephen KSVP & Chief Scientific Officer02/17/20164,649
Thomsen Jillian B.SVP & Chief Accounting Officer02/16/20160
Thomsen Jillian B.SVP & Chief Accounting Officer02/17/20168,535
Labrucherie Gil MSVP & General Counsel02/16/20160
Labrucherie Gil MSVP & General Counsel02/17/20169,858
Hora ManinderSVP Pharma Dev & Mfg Ops02/16/20160
Hora ManinderSVP Pharma Dev & Mfg Ops02/17/201611,479
Labrucherie Gil MSVP & General Counsel02/10/201675,362
Labrucherie Gil MSVP & General Counsel02/10/2016134,042
Thomsen Jillian B.SVP & Chief Accounting Officer02/10/201699,750
Thomsen Jillian B.SVP & Chief Accounting Officer02/10/2016172,350
ROBIN HOWARD WPresident & CEO02/10/2016430,662
ROBIN HOWARD WPresident & CEO02/10/2016765,992
Thomsen Jillian B.SVP & Chief Accounting Officer01/19/201699,750
Thomsen Jillian B.SVP & Chief Accounting Officer01/19/2016211,800
ROBIN HOWARD WPresident & CEO01/19/2016430,669
ROBIN HOWARD WPresident & CEO01/19/2016941,338
Lingnau LutzDirector01/20/201677,250
Lingnau LutzDirector01/20/2016217,650
Labrucherie Gil MSVP & General Counsel01/19/201675,369
Labrucherie Gil MSVP & General Counsel01/19/2016164,738
Labrucherie Gil MSVP & General Counsel12/03/2015308,040
Labrucherie Gil MSVP & General Counsel12/03/2015714,166
ROBIN HOWARD WPresident & CEO12/03/2015837,840
ROBIN HOWARD WPresident & CEO12/03/20151,983,766
KUEBLER CHRISTOPHER ADirector12/04/201577,250
KUEBLER CHRISTOPHER ADirector12/04/2015237,300
Thomsen Jillian B.SVP & Chief Accounting Officer12/03/201599,750
Thomsen Jillian B.SVP & Chief Accounting Officer12/03/2015238,050
WANG SUSANDirector11/18/2015153,162
WANG SUSANDirector11/20/2015418,430
WANG SUSANDirector11/19/201577,758
WANG SUSANDirector11/18/2015305,580
WANG SUSANDirector11/20/2015743,490
WANG SUSANDirector11/19/2015227,223
ROBIN HOWARD WPresident & CEO11/11/2015837,833
ROBIN HOWARD WPresident & CEO11/11/20151,690,000
Labrucherie Gil MSVP & General Counsel11/11/2015308,033
Labrucherie Gil MSVP & General Counsel11/11/2015608,400
Thomsen Jillian B.SVP & Chief Accounting Officer11/11/201599,750
Thomsen Jillian B.SVP & Chief Accounting Officer11/11/2015202,800
Lingnau LutzDirector10/28/201583,125
Lingnau LutzDirector10/28/2015150,000
GREER R SCOTTDirector10/15/2015368,550
ROBIN HOWARD WPresident & CEO10/06/2015837,833
ROBIN HOWARD WPresident & CEO10/06/20151,373,750
Labrucherie Gil MSVP & General Counsel10/06/2015308,033
Labrucherie Gil MSVP & General Counsel10/06/2015494,550
Thomsen Jillian B.SVP & Chief Accounting Officer10/06/201599,750
Thomsen Jillian B.SVP & Chief Accounting Officer10/06/2015164,850
Thomsen Jillian B.SVP & Chief Accounting Officer09/23/201566,500
Thomsen Jillian B.SVP & Chief Accounting Officer09/23/2015130,400
ROBIN HOWARD WPresident & CEO09/23/2015837,827
ROBIN HOWARD WPresident & CEO09/23/20151,629,987
Labrucherie Gil MSVP & General Counsel09/23/2015308,027
Labrucherie Gil MSVP & General Counsel09/23/2015586,787
WHITFIELD ROY ADirector09/11/2015132,150
Labrucherie Gil MSVP & General Counsel08/13/2015232,664
Labrucherie Gil MSVP & General Counsel08/13/2015362,996
ROBIN HOWARD WPresident & CEO08/13/2015407,164
ROBIN HOWARD WPresident & CEO08/13/2015635,246
Nicholson JohnSVP & Chief Financial Officer08/12/2015584,000
Nicholson JohnSVP & Chief Financial Officer08/11/20152,437,100
Nicholson JohnSVP & Chief Financial Officer08/11/20152,716,089
Nicholson JohnSVP & Chief Financial Officer08/12/2015733,325
Krivulka Joseph JDirector07/24/2015132,150
ROBIN HOWARD WPresident & CEO07/14/2015407,171
ROBIN HOWARD WPresident & CEO07/14/2015687,175
Labrucherie Gil MSVP & General Counsel07/14/2015232,671
Labrucherie Gil MSVP & General Counsel07/14/2015392,675
WANG SUSANDirector06/29/2015209,400
WANG SUSANDirector06/29/2015381,000
CHESS ROBERTDirector06/19/2015132,150
CHESS ROBERTDirector06/19/2015177,150
Lingnau LutzDirector06/15/2015166,250
Lingnau LutzDirector06/15/2015278,750
KUEBLER CHRISTOPHER ADirector01/13/2015132,150
KUEBLER CHRISTOPHER ADirector01/13/2015240,000
CHESS ROBERTDirector12/29/2014449,580
CHESS ROBERTDirector12/29/2014452,530
Thomsen Jillian B.SVP & Chief Accounting Officer12/22/201456,900
Thomsen Jillian B.SVP & Chief Accounting Officer12/22/201477,800
Labrucherie Gil MSVP & General Counsel12/01/2014139,500
Labrucherie Gil MSVP & General Counsel11/28/2014418,500
Labrucherie Gil MSVP & General Counsel12/01/2014510,000
Labrucherie Gil MSVP & General Counsel11/28/20141,531,800
ROBIN HOWARD WPresident & CEO12/01/20141,459,211
ROBIN HOWARD WPresident & CEO11/28/2014983,789
ROBIN HOWARD WPresident & CEO11/28/20142,398,867
ROBIN HOWARD WPresident & CEO12/01/20143,553,952
Labrucherie Gil MSVP & General Counsel11/24/2014136,710
Labrucherie Gil MSVP & General Counsel11/24/2014157,920
ROBIN HOWARD WPresident & CEO11/25/20146,783,744
ROBIN HOWARD WPresident & CEO11/24/20141,928,256
ROBIN HOWARD WPresident & CEO11/24/20141,994,656
ROBIN HOWARD WPresident & CEO11/25/20147,152,832
Lingnau LutzDirector11/24/2014132,150
Lingnau LutzDirector11/24/2014225,300
Labrucherie Gil MSVP & General Counsel11/03/2014112,662
Labrucherie Gil MSVP & General Counsel11/03/2014136,422
KUEBLER CHRISTOPHER ADirector08/05/2013142,625
KUEBLER CHRISTOPHER ADirector08/05/2013155,125
WHITFIELD ROY ADirector08/05/2013142,625
WHITFIELD ROY ADirector08/05/2013155,125
KUEBLER CHRISTOPHER ADirector09/27/2012108,250
KUEBLER CHRISTOPHER ADirector09/27/2012133,250
WINGER DENNIS LDirector09/14/201245,908
CHESS ROBERTDirector07/13/2012146,886
CHESS ROBERTDirector07/13/2012204,009
CHESS ROBERTDirector03/08/201140,500
Load More Insider Transactions
FUNDS WITH A POSITION IN NEKTAR THERAPEUTICS
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.6,104,2170.00009%-20.57%Other
RENAISSANCE TECHNOLOGIES LLC5,325,4750.00466%51.87%Other
D. E. SHAW & CO., INC.4,098,8440.00202%-33.06%Other
GEODE CAPITAL MANAGEMENT, LLC2,039,6140.00012%4.31%Other
AQR CAPITAL MANAGEMENT LLC1,435,5490.00153%-60.84%Other
UBS OCONNOR LLC1,250,7420.05%-9.12%Value
BALYASNY ASSET MANAGEMENT L.P.1,100,0000.00117%-17.52%Event Driven
TUDOR INVESTMENT CORP ET AL57,0830.00026%No changeEvent Driven, Other
CHANGE IN SHARES OUTSTANDING FOR NEKTAR THERAPEUTICS
STOCK BUYBACKS FOR NEKTAR THERAPEUTICS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.34%
1Q
12/31/2023
06/30/2023
0.74%
2Q
12/31/2023
03/31/2023
1.15%
3Q
12/31/2023
12/31/2022
1.49%
4Q
12/31/2023
09/30/2022
1.82%
5Q
12/31/2023
06/30/2022
2.28%
6Q
12/31/2023
03/31/2022
2.80%
7Q
12/31/2023
12/31/2021
3.28%
8Q
12/31/2023
09/30/2021
3.77%
9Q
12/31/2023
06/30/2021
4.57%
10Q
12/31/2023
03/31/2021
5.34%
11Q
12/31/2023
12/31/2020
6.31%
12Q
12/31/2023
09/30/2020
6.68%
13Q
12/31/2023
06/30/2020
7.14%
14Q
12/31/2023
03/31/2020
7.83%
15Q
12/31/2023
12/31/2019
8.46%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.34%
1Q
06/30/2023
0.74%
2Q
03/31/2023
1.15%
3Q
12/31/2022
1.49%
4Q
09/30/2022
1.82%
5Q
06/30/2022
2.28%
6Q
03/31/2022
2.80%
7Q
12/31/2021
3.28%
8Q
09/30/2021
3.77%
9Q
06/30/2021
4.57%
10Q
03/31/2021
5.34%
11Q
12/31/2020
6.31%
12Q
09/30/2020
6.68%
13Q
06/30/2020
7.14%
14Q
03/31/2020
7.83%
15Q
12/31/2019
8.46%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NEKTAR THERAPEUTICS
LOADING...